The QualityStocks Daily Friday, December 9th, 2022

Today's Top 3 Investment Newsletters

QualityStocks(AMAM) $4.5400 +1,007.59%

QualityStocks(HTGM) $0.5400 +117.57%

Schaeffer's(MOMO) $8.9300 +31.52%

The QualityStocks Daily Stock List

China Jo-Jo Drug Stores (CJJD)

MarketBeat, QualityStocks, SmallCapVoice, BUYINS.NET, StocksEarning, StockOodles, StreetInsider, The Street, StockRockandRoll, The Online Investor, ResearchOTC,, Street Insider, Wall Street Resources, The Weekly Options Trader, PennyTrader Publisher, Penny Stock Rumble, TradersPro, Market Report and StockMarketWatch reported earlier on China Jo-Jo Drug Stores (CJJD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

China Jo-Jo Drugstores Inc. (NASDAQ: CJJD) (FRA: 04CN) is engaged in the distribution and retail of pharmaceutical products as well as other healthcare products in China.

The firm has its headquarters in Hangzhou, the People’s Republic of China and was incorporated in 2006, on December 19th by Li Qi and Lei Liu. It operates in the consumer staples sector, under the retail and wholesale industry. The firm serves consumers in China.

The enterprise operates through the following segments: herb farming, drug wholesale, online pharmacy and retail drugstores. The farming segment grows various herbs which are sold to other drug vendors while the wholesale segment is engaged in the supply of the enterprise’s drug stores with medications, sundry items and medical devices. Additionally, the drugstores segment is involved in the sale of medical devices, family and personal care products, traditional Chinese medicine, nutritional supplements, over-the-counter and prescription medications and convenience products which include promotional, seasonal and consumable items. The online pharmacy is involved in the sale of nutritional supplements and other products via 3rd party platforms like and as well as its own platform, called

As of March 31, 2020, the company had 10 pharmacies and over 115 retail pharmacies under the Jiuzhou Grand Pharmacy name. The firm received the CHEO Award from the China Health Ecology Organization in September 2020, which is a health industry conference that has great influence and high standards. This award helps boost confidence in the firm, which is actively striving to promote their smart medicine diagnosis model.

China Jo-Jo Drug Stores (CJJD), closed Friday's trading session at $3.31, up 51.2037%, on 2,545,668 volume. The average volume for the last 3 months is 41.997M and the stock's 52-week low/high is $1.43/$5.748.

CGrowth Capital (CGRA)

PennyStocks24, QualityStocks, Penny Stocks VIP, Penny Pick Insider, Daily Stock Motion, Jet-Life Penny Stocks, OTPicks, Penny Investor Network, Penny Picks, Pumps and Dumps, MarketClub Analysis, PennyDoctor, InvestorPlace, Winston Small Cap, OTCMagic, OTC Magic, Wallstreetlivechat, OTCPicks, Greenbackers, TheMicrocapNews, Damn Good Penny Picks, Whisper from Wall Street, Center Stage Stocks, AllPennyStocks, AimHighProfits, InsideBulls, Penny Dreamers, OtcWizard, Stock Twiter, Penny Champions, 007 Stock Chat, The Observer, Penny Stock Newsletter, StockRunway, Penny Trackers, Stockgoodies, PennyStockSpy,, Promotion Stock Secrets and Otcstockexchange reported earlier on CGrowth Capital (CGRA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

CGrowth Capital Inc. (OTC: CGRA) is a holding firm for assets and businesses that is focused on exploration, mineral and mining activities and also commercial real estate in the U.S.

The firm has its headquarters in Silverdale, Washington and was incorporated in 1986, on October 30th. Prior to its name change in February 2010, the firm was known as Anchor Pacific Underwriters Inc.

The enterprise’s solutions and services have been designed to help land owners monetize undervalued assets by bringing commodities like gas and oil, silver, gold and dolomite to market. It builds value via the proving of reserves and generating revenues from its many projects. The enterprise is actively engaged in evaluating opportunities in the burgeoning legalized marijuana and hemp sectors.

The company is focused on the acquisition of land assets while also offering affiliates and partners with logistical, contract management, capital and management services necessary for operation execution. This is in addition to offering processing applications and support for land owners. It owns roughly 50 acres of industrial property in Chewelah, Washington; more than 1100 acres of oil leases in Louisiana and about 3400 acres of oil leases in the Powder River Basin. Its gas and oil division Powder River Resources Inc. is an independent gas and oil exploration firm.

The firm has plans to enter into a partnership initiative with Inc. which will help finance and develop a marijuana retail and industrial epicenter. If successful, the venture will bring in additional revenue as well as encourage more investors to inject funds into the firms, which will in turn boost its growth.

CGrowth Capital (CGRA), closed Friday's trading session at $0.078, up 94.5137%, on 41,996,967 volume. The average volume for the last 3 months is 123.794M and the stock's 52-week low/high is $0.0048/$0.162.

Ambrx Biopharma (AMAM)

MarketBeat and QualityStocks reported earlier on Ambrx Biopharma (AMAM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Ambrx Biopharma Inc. (NYSE: AMAM) is a clinical-stage biologics firm that is focused on the discovery and development of engineered precision biologics through the use of its proprietary expanded genetic code technology platform.

The firm has its headquarters in La Jolla, California and was incorporated in 2003. It operates as part of the pharmaceutical and medicine manufacturing industry, under the healthcare sector. The firm serves consumers in the United States.

The company is party to collaborations with a number of pharmaceutical companies, including Elanco Animal Health, Astellas Pharma Inc., and the Bristol Myers Squibb Company.

The enterprise’s product portfolio is comprised of an anti-HER2 ADC (antibody-drug conjugate) dubbed ARX788, which is in a phase II/III clinical trial testing its efficacy in treating gastric cancer and HER2-positive metastatic breast cancer as well as undergoing various clinical trials evaluating its effectiveness in treating gastric/gastroesophageal junction cancer, breast cancer and other solid tumors. It is also developing an anti-CD70 ADC known as ARX305, which is under study for the treatment of renal cell carcinoma and other cancers; and an anti-PSMA ADC dubbed ARX517, for the treatment of prostate cancer and other solid tumors. In addition to this, the enterprise is developing a fab-small molecule bispecific known as ARX822, which is in preclinical development for various oncological indications; and an immune-oncology IL-2 pathway agonist dubbed ARX102.

The company’s ARX788 formulation presented positive safety and effectiveness data in its clinical trial for the treatment of breast cancer. The company is focused on advancing its clinical candidates to create better treatment outcomes for patients, and growing to create value for its stakeholders.

Ambrx Biopharma (AMAM), closed Friday's trading session at $4.54, up 1007.59%, on 123,794,140 volume. The average volume for the last 3 months is 45.438M and the stock's 52-week low/high is $0.38/$10.4999.

HTG Molecular Diagnostics (HTGM)

StockMarketWatch, TraderPower, MarketClub Analysis, BUYINS.NET, MarketBeat, QualityStocks,, Promotion Stock Secrets, StockOodles, The Street, Wall Street Mover, AllPennyStocks,, Money Morning, StreetInsider, The Online Investor, TopPennyStockMovers and Schaeffer's reported earlier on HTG Molecular Diagnostics (HTGM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

HTG Molecular Diagnostics Inc. (NASDAQ: HTGM) (FRA: 65HA) is a life sciences firm that is focused on the advancement of precision medicine via innovative profiling technology designed to hasten discovery of new drug candidates and develop diagnostics.

The firm has its headquarters in Tucson, Arizona and was incorporated in October 1997 by Bruce E. Seligmann. Prior to its name change in March 2011, the firm was known as HTG Inc. It operates as part of the diagnostics and research industry, under the healthcare sector. The firm serves consumers around the world, with a focus on Europe and the United States.

The enterprise is party to an agreement with QIAGEN Manchester Ltd. The enterprise provides assay kits, software which automates processing of samples and profiles for different molecular targets, and instruments. Its molecular profiling panels include the mRNA tumor response panel; the immune response panel; the EdgeSeq ALKPlus assay EU; the EdgeSeq Oncology Biomarker panel; the DLBCL cell of origin assay; the miRNA whole-transcriptome assay; and the Transcriptome Panel. The enterprise distributes its consumables and instruments directly in Europe and the U.S., as well as via distributors in various parts of Europe and internationally. It serves biopharmaceutical firms, molecular testing laboratories and academic research centers.

The company recently expanded its therapeutics team with the addition of an experienced program leader in drug discovery and development. This move will bolster its efforts to introduce new therapeutic candidates to the market, which will benefit patients with various indications and bring in more revenues into the company as well.

HTG Molecular Diagnostics (HTGM), closed Friday's trading session at $0.54, up 117.5665%, on 45,437,787 volume. The average volume for the last 3 months is 200,205 and the stock's 52-week low/high is $0.1987/$5.68.

Exscientia PLC (EXAI)

The Street, Real Pennies and MarketBeat reported earlier on Exscientia PLC (EXAI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Exscientia Plc (NASDAQ: EXAI) (FRA: 0RK) is a pharmatech firm that is focused on the discovery, design and development of the best possible drugs in the fastest and most effective manner.

The firm has its headquarters in Oxford, the United Kingdom and was incorporated in 2012. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers in the United Kingdom.

The artificial intelligence-driven company has developed a precision oncology platform that can successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, while also progressing AI-designed small molecules into the clinical setting. It generates revenue from service fees related to drug discovery collaboration agreements it is utilizing its proprietary technology to develop novel Intellectual Property (IP) and licensing fees related to drug discovery agreements.

The enterprise’s AI process is comprised of five elements, including Precision Target, Precision Design, Precision Experiment, Precision Medicine and Presentations and Publications. Its internal pipeline is focused on leveraging their precision medicine platform in oncology, while its partnered pipeline broadens the firm’s approach to other therapeutic areas. Its lead drug candidate, EXS21546, is still in its early stage of development.

The firm recently entered into a strategic collaboration with Te University of Texas MD Anderson Cancer Center, which will help drive development of next generation oncology treatments that can offer meaningful benefits to patients. This is in addition to opening the firm up to new growth and investment opportunities and creating value for its shareholders.

Exscientia PLC (EXAI), closed Friday's trading session at $5.11, up 3.0242%, on 200,205 volume. The average volume for the last 3 months is 1.846M and the stock's 52-week low/high is $4.90/$24.99.

Provectus Biopharmaceuticals (PVCT)

plrinvest, QualityStocks, Streetwise Reports, Stock News Now, Real Pennies, Investor Spec Sheet, PennyStocks24, SmarTrend Newsletters, The Street, MarketBeat, TopPennyStockMovers, Investors Underground, PennyTrader Publisher, PennyOmega, Penny Sleuth, DrStockPick, CRWEWallStreet, CRWEPicks, CRWEFinance, Club Penny Stocks Network, BestOtc, FeedBlitz, PennyToBuck, Wealth Daily, TopStockAnalysts, Wise Alerts, Seeking Alpha, Standout Stocks, StockHotTips, StreetAuthority Daily, StreetInsider, TheMicrocapNews, TheStockAdvisor, TheStockAdvisors and AllPennyStocks reported earlier on Provectus Biopharmaceuticals (PVCT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Provectus Biopharmaceuticals Inc. (OTCQB: PVCT) is a clinical-stage biotechnology firm that is focused on the development of immunotherapy medications based on halogenated xanthenes.

The firm has its headquarters in Knoxville, Tennessee and was incorporated in 2002 by Eric A. Wachter. Prior to its name change in December 2013, the firm was known as Provectus Pharmaceuticals Inc. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers around the globe.

The enterprise develops ethical pharmaceuticals for oncology and dermatology indications. Its pipeline is comprised of an investigational autolytic cancer immunotherapy dubbed PV-10, for gastrointestinal tumors, including hepatocellular carcinoma and adult solid tumor cancers, such as melanoma; neuroendocrine tumors metastatic to the liver; uveal melanoma metastatic to the liver; colorectal cancer metastatic to the liver; and pediatric solid tumor cancers, such as Ewing sarcoma,neuroblastoma, osteosarcoma and rhabdomyosarcoma. It also develops oral formulations of cGMP RBS for the treatment of pediatric blood cancers, including leukemia; and adult solid tumor cancers, such as head and neck, breast, testicular, and colorectal cancers. This is in addition to developing an investigational immuno-dermatology agent dubbed PH-10, for the treatment of inflammatory dermatoses, such as atopic dermatitis and psoriasis.

The company recently expanded its research program with The Rockefeller University, which involves investigating the potential for PH-10 in treating inflammatory skin conditions. This move not only opens the company up to new growth opportunities but also brings it one step closer to getting its PH-10 candidate approved.

Provectus Biopharmaceuticals (PVCT), closed Friday's trading session at $0.105, off by 8.9727%, on 1,846,113 volume. The average volume for the last 3 months is 18,824 and the stock's 52-week low/high is $0.034/$0.1895.

MamaMancini's Holdings (MMMB)

QualityStocks, TaglichBrothers, TradersPro, MarketBeat, StocksEarning, SmallCapVoice, Trading Concepts, TheMicrocapNews, The Street, Stock News Now, OTC Markets Group,, BUYINS.NET and AllPennyStocks reported earlier on MamaMancini's Holdings (MMMB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

MamaMancini's Holdings Inc. (NASDAQ: MMMB) is a company involved in manufacturing and distributing of specialty prepared, frozen and refrigerated food products.

The firm has its headquarters in East Rutherford, New Jersey and was incorporated in 2010 by Daniel Mancini and Daniel Dougherty. It operates as part of the packaged foods industry, under the consumer defensive sector. The firm serves consumers in the United States, with a focus on those in the Northeast and Southeast regions of the country.

The enterprise’s products include turkey and beef meatballs, chicken, meat loaf, pasta entrees and sausage-related products, all of which are slow cooked with Italian sauce. It also provides a range of product lines including single-size Pasta Bowls, ready to serve dinners, bulk deli, packaged refrigerated and frozen products. The enterprise sells its products on QVC through live on-air offerings, auto ship programs and on their Website, in addition to selling them in the fresh meat and frozen food sections, directly to both food retailers and food distributors. Its distribution channel includes major retailers like Shop Rite, Publix, Sam's Club, Lucky’s, SaveMarts, Safeway, Lunds/Byerly's, King Kullen, SuperValu, Hy Vee, Albertsons, Marsh’s Supermarkets, Spartan Stores, Shoppers, Bashas, Kroger, Whole Foods, Schnuck Markets, Shaw's Supermarkets, Topps Supermarkets, Kings, Central Grocers, Roche Brothers, AGI Stores, Key Foods, Giant Eagle ,Stop-n-Shop and Giant Stores.

The company, which recently announced its latest financial results, remains committed to expanding its distribution channels, driving organic growth and positioning itself to build sustainable value for its shareholders over the long-term.

MamaMancini's Holdings (MMMB), closed Friday's trading session at $1.1198, off by 0.902655%, on 18,824 volume. The average volume for the last 3 months is 23,111 and the stock's 52-week low/high is $0.9298/$2.24.

Valeura Energy (PNWRF)

PoliticsAndMyPortfolio and Wall Street Mover reported earlier on Valeura Energy (PNWRF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Valeura Energy Inc. (OTC: PNWRF) (TSE: VLE) (FRA: 83PN) is an upstream oil and gas firm that is focused on exploring for, developing and producing petroleum and natural gas in Turkey.

The firm has its headquarters in Calgary, Canada and was incorporated in 2000, on June 12th by James D. McFarland. It operates as part of the oil and gas E&P industry, under the energy sector. The firm serves consumers in Europe and the rest of the world.

The company specializes in the exploration of basin-centered and unconventional gases. It operates through its subsidiaries, which are located in Turkey, the Netherlands, Singapore, Thailand, the Cayman Islands and the British Virgin Islands. They include Northern Hunter Energy Inc., Valeura Energy Inc., Valeura Energy (Gulf of Thailand) Ltd., Valeura Energy (Thailand) Company Ltd., Valeura Energy (Thailand) Holdings Ltd. (BVI),Valeura (BVI) Holdings Ltd., Valeura Energy Asia Pte Ltd and Valeura Energy (Netherlands) BV.

The enterprise holds a significant land position in the Thrace basin of Turkey, located west of Istanbul, where it is pursuing a deep, tight gas play estimated to hold 20.0 Tcfe of natural gas resource. It also holds an operated interest in a pair of oil fields in the offshore Gulf of Thailand, which contain proved and probable reserves of 6.5 million bbls of oil plus 2C unrisked contingent resources of 13.3 million barrels of oil equivalent.

The firm recently entered into a sale and purchase agreement to acquire the Thailand upstream oil producing portfolio of Busrakham Oil and Gas Ltd from Mubadala Petroleum Ltd. This move not only adds to the firm’s portfolio significantly but will also drive revenues as well as growth.

Valeura Energy (PNWRF), closed Friday's trading session at $1.18, up 18%, on 23,111 volume. The average volume for the last 3 months is 101,266 and the stock's 52-week low/high is $0.12/$1.50.

Xunlei Ltd (XNET)

StocksEarning, MarketClub Analysis, StockEarnings, StockMarketWatch, MarketBeat, Schaeffer's, TopPennyStockMovers, BUYINS.NET, PoliticsAndMyPortfolio, Wall Street Mover, Street Insider, The Street, TradersPro, StreetInsider, Zacks, Promotion Stock Secrets, Profit Confidential, InvestorPlace, FreeRealTime and QualityStocks reported earlier on Xunlei Ltd (XNET), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Xunlei Ltd (NASDAQ: XNET) (FRA: 4XN) is a cloud-based acceleration technology firm which operates an internet platform for digital media content.

The firm has its headquarters in Shenzhen, China and was incorporated in December 2002 by Hao Cheng and Sheng Long Zou. Prior to its name change in January 2011, the firm was known as Giganology Ltd. It operates as part of the advertising agencies industry, under the communication services sector. The firm serves consumers in the People’s Republic of China.

The enterprise's platform is based on cloud technology that allows users to access, store, manage, and consume digital media content. It provides a mobile application dubbed Mobile Xunlei, which enables users to search, download, and consume digital media content; the Xunlei Accelerator, which enables users to accelerate digital transmission over the internet; and the Xunlei Media Player, which supports offline and online play of digital media content, as well as simultaneous play of digital media content while it is being transmitted by Xunlei Accelerator. The enterprise also offers cloud acceleration subscription services that provide premium services to users via a range of products, including Green Channel; online games through its online game website and mobile app; cloud computing and other internet value-added services; and live video streaming and online advertising services.

The company recently announced its latest financial results, which show increases in its total revenues. It remains focused on effectively executing its growth strategy and capturing long-term opportunities, which will bolster its overall growth significantly.

Xunlei Ltd (XNET), closed Friday's trading session at $2, off by 3.3816%, on 101,266 volume. The average volume for the last 3 months is 5.451M and the stock's 52-week low/high is $0.845/$2.545.

QuantumScape Corp. (QS)

InvestorPlace, Schaeffer's, StocksEarning, MarketClub Analysis, The Street, The Online Investor, MarketBeat, Daily Trade Alert, QualityStocks, Top Pros' Top Picks, TipRanks, wyatt research newsletter, Atomic Trades, Trades Of The Day, CNBC Breaking News and BUYINS.NET reported earlier on QuantumScape Corp. (QS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

In a first of its kind since 2010, the cost of batteries has increased. These higher prices, coupled with rising costs of raw materials, are projected to hamper the spread and use of electric vehicles around the world.

A report authored by BNEF indicated that the price of batteries rose to an average of 151/kwh, showing a slight increase of 7% from a year earlier. This increase was a result of the rising prices for battery metals such as lithium and cobalt, as well as nickel. However, in the coming years, these prices are predicted to increase even more.

The $100 per kilowatt-hour mark has been identified by the automotive industry as the threshold at which EVs will become competitively priced with fuel-powered cars. However, the skyrocketing costs of lithium, which have multiplied tenfold since the beginning of 2021, along with nickel’s 75% increase and this year’s cobalt prices, which have doubled their average over 2020, have pushed battery prices upwards.

In this regard, BloombergNEF predicts a two-year delay, which means the $100 per kilowatt-hour level could be reached as early as 2026. This is a significant transitional risk that will have a negative impact on carmakers’ ability to manufacture and sell an increasing number of electric vehicles in regions without EV incentives.

Actually, the price of batteries would have increased significantly if Chinese battery and automobile manufacturers hadn’t chosen LFP batteries, which are significantly less expensive because they don’t use expensive metals such as nickel and cobalt. Because of its low cost, this year saw the demand for LFP increase by almost twofold to 603 GWh compared to last year.

Depending on where you are, LFP battery packs can still be costly. They cost, on average, $127 per kilowatt-hour in China, as opposed to 24% more in the United States and 33% more in Europe. The difference in cost is that long-range battery packs made of expensive metals are preferred by the western market, while underdeveloped markets incur high cost of production.

The report’s lead author, Evelina Stoikou, an energy storage associate at BNEF, said that price increases for raw materials and individual components were the main causes of the rise in cell prices seen in 2022. As battery metal prices continue to soar, the main battery and car producers have adopted much more intensive approaches to safeguard against price fluctuations, including investment in mines and refinery projects.

The time when there will be a reduction in the cost of battery metals is still a mystery. Countries in Europe as well as other countries around the world, including the United States, are attempting to reduce their reliance on China for battery supply. However, the leading producers of lithium have issued a warning about the complexities of raising production to meet the skyrocketing demand for batteries.

As things stand, the future of the EV industry could be resting in the hands of battery makers such as QuantumScape Corp. (NYSE: QS), which have to come up with ways to lower battery costs despite the rising prices of battery metals.

QuantumScape Corp. (QS), closed Friday's trading session at $7.11, up 2.1552%, on 5,450,771 volume. The average volume for the last 3 months is 243,144 and the stock's 52-week low/high is $6.605/$26.40.

Compass Minerals International Inc. (CMP)

SmarTrend Newsletters, MarketBeat, The Online Investor, QualityStocks, Daily Trade Alert, Trades Of The Day,, Kiplinger Today, InvestorPlace, The Street, StreetAuthority Daily, Zacks, Schaeffer's, StreetInsider, MarketClub Analysis, All about trends, Top Pros' Top Picks, The Stock Dork, Insider Wealth Alert, Wyatt Investment Research, Daily Market Beat, CRWEFinance, BUYINS.NET, Barchart and Daily Wealth reported earlier on Compass Minerals International Inc. (CMP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Carbon dioxide (CO2) is usually used by plants for photosynthesis, which supplies them with their sugars. Plants cannot survive on this alone, however, and usually need nutrients such as iron, phosphorus and nitrogen, which they absorb from the soil using their roots. While carbon dioxide is important, scientists conducting a review of current and past research on how different levels of CO2 affect plants have determined that increasing levels of carbon dioxide make it harder for plants to obtain the nutrients they require for growth from the soil.

Antoine Martin, a biologist at the National Center for Scientific Research in France, explained that the nutrient composition of widely used crops such as wheat and rice was negatively affected by increased carbon dioxide levels, noting that this would have a strong impact on food security globally as well as food quality. A biologist at the National Research Institute for Agriculture, Food and the Environment in France, Alain Gojon, added that some reports had also shown that the carbon dioxide levels expected at the end of this century would cause nitrogen concentration to be lower in most plants, which would, in turn, affect the protein content in plant products.

Scientists had first observed this under experimental conditions more than two decades ago. Now, the phenomenon has also been established in the natural environment.

Long-term research on forests also demonstrated reductions in minerals found in foliage. This is backed by archived samples from the 20th century, which show that in comparison to today’s plants, plants from decades ago had higher nutrient content. Additionally, scientists have determined that plants which grow in locations that have naturally higher atmospheric carbon dioxide, such as volcanoes, have lower levels of nitrogen levels.

Gojon also argued that the two nutrients important for human nutrition — iron and nitrogen — would be affected by this. He explained that plants grown at increased carbon dioxide levels could have 20% to 30% less protein, which could be a serious issue, especially since most diets in developing countries weren’t rich in proteins. Gojon added that iron deficiency, which currently affects about two billion individuals globally, would become an even bigger issue.

Scientists are requesting that more research into the matter be conducted, noting that finding ways to inhibit an increase in carbon dioxide levels would not only be good for plants but also help us advance in the fight against climate change.

The review’s findings were reported in “Trends in Plant Science.

The adverse effects of too much CO2 on plant nutrition are likely to give fertilizer makers such as Compass Minerals International Inc. (NYSE: CMP) plenty to think about as they try to optimize their formulations so that plants can still benefit from supplemental nutrients.

Compass Minerals International Inc. (CMP), closed Friday's trading session at $42.85, off by 0.947758%, on 243,144 volume. The average volume for the last 3 months is 367,773 and the stock's 52-week low/high is $30.67/$67.665.

Bit Mining Ltd. (BTCM)

QualityStocks, MarketClub Analysis, Schaeffer's and StocksEarning reported earlier on Bit Mining Ltd. (BTCM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

There is still a glimmer of hope for the cryptocurrency industry, despite the major blow it suffered after the FTX exchange and its affiliated trading firm, Alameda Research, was reported bankrupt. This is according to a research report released by Bank of America on Nov. 2, 2022.

According to the report, regulatory frameworks for the cryptocurrency industry are essential for mainstream adoption, and a coordinated global effort is needed to prevent arbitrage and protect investors and consumers.

Analysts Alkesh Shah and Andrew Moss also noted an increased sense of urgency to regulate the industry. The analysts explained potential benefits, including better facilitation of institutional engagement as well as allowing a focus shift coupled with moving capital away from trading speculatively and toward projects having real-world usability.

The bank notes that the failure of FTX has brought attention back to the need for regulations that create a transparent legal framework for digital assets, foster technological innovation, provide consumer and investor protection, and mitigate financial stability risks.

There are significant costs associated with ignoring digital assets, according to the bank. For example, the bank pointed out, the top 100 crypto tokens have lost 64% of their value so far this year, but they are still up 2,175% since the end of 2016.

This year, there has been a rapid increase in the development of blockchains with smart contract functionality and applications. While speculative trading may be common, the “underlying blockchain technology that is driving this speculation could be revolutionary,” said the report.

The Bank of America warns that retail and institutional disengagement could put additional pressure on cryptocurrency prices but points out that the 22% decline in digital asset prices between Nov. 2–10, 2022, was followed by a 6% increase through Nov. 25, 2022, suggesting that investors may be shifting their attention to the long-term disruption potential of blockchain technology.

That disruption is already manifesting in diverse ways. For example, central banks such as the New York Fed are conducting pilot programs to study how the benefits of blockchain technology can be brought to the traditional banking industry to increase speed, cut costs and make the process more efficient overall.

The technology is also finding application in smart cities as utilities, Wi-Fi providers and local authorities look to this technology to enhance service delivery and improve accessibility for communities that have been underserved for long. It is therefore unsurprising that as companies such as Bit Mining Ltd. (NYSE: BTCM) deepen their penetration, more and more people are changing their attitudes about these novel technologies.

Bit Mining Ltd. (BTCM), closed Friday's trading session at $0.2375, up 3.2609%, on 367,773 volume. The average volume for the last 3 months is 201,964 and the stock's 52-week low/high is $0.1888/$7.19.

The QualityStocks Company Corner

FingerMotion Inc. (NASDAQ: FNGR)

The QualityStocks Daily Newsletter would like to spotlight FingerMotion Inc. (NASDAQ: FNGR) .

FingerMotion (NASDAQ: FNGR), a mobile data and services company, today announced that itssubsidiary, Shanghai JiuGe Information Technology Co. Ltd. (“JiuGeTechnology”) and Munich Re, a large global reinsurer, have set thestage for extension of their ongoing behavioral research andanalytic studies into commercial implementation in the Chinamarket. The partner companies, through a proprietary behaviorintelligence system developed by “Sapientus,” the analyticinnovation development arm of FingerMotion, will bring forwardtheir jointly developed model algorithms and analytic insights forproductionized applications and wider market adoption. “We areexcited to walk together with Munich Re in driving commercialapplication of our work,” said Martin Shen, CEO of FingerMotion.“Today’s news reinforces a longer-term strategic mission toreinvent the way our partners provide insurance to customers in thefuture. We cannot stress more on addressing consumer demands for amore convenient insurance experience through analytic innovation.With this collaboration, we are well on our way towards realizingthis common goal with our insurer partners in the near future.”

To view the full press release, visit

FingerMotion Inc. (NASDAQ: FNGR) is an evolving technological company with core competencies in mobile payment and recharge platform solutions in China. FingerMotion is in the process of developing additional value-added technologies to market to users.

Founded in 2016, FingerMotion’s goal is to serve over a billion users in the Chinese market and expand its model to other regional markets. The company has offices in Hong Kong, Shanghai and New York City.

Current Offerings

FingerMotion is analyzing and transforming mobile data to improve the lifestyle of the public through technology and innovation. The company’s current offerings include:

  • Telecommunications Products and Services – FingerMotion’s proprietary universal exchange platform, ‘PigeonHole Integration System (PIS)’, offers seamless integration between telecom operators and online stores. The service platform’s offerings include top up and recharge, data plan, mobile phone, loyalty points redemption and subscription plans. The platform offers reliable and secure transactions, real-time reconciliation, simple integration for partners and efficient settlements.
  • SMS and MMS Services – The integrated platform is registered as FingerMotion’s IP in China and provides a robust back-end control panel for corporate partners to manage their own messaging settings. FingerMotion’s clients range from insurance to financial industries, ecommerce firms, airlines and more. The platform offers competitive pricing for partners and provides quick and efficient review to meet timely marketing initiatives.
  • Big Data Insights – FingerMotion brings Big Data-enabled insurance solutions through its Big Data Insights arm, Sapientus. The company’s strategic partnerships with the largest Chinese telecommunications giants allow access to uncover behavior insights through geolocation and mobile data usage. Its Big Data offerings include risk scoring, precise marketing, simplified underwriting and customized products.
  • Rich Communication Services (RCS) – FingerMotion’s RCS platform will be a proprietary business messaging solution that enables businesses and brands to communicate their services to customers via 5G infrastructure. The company expects its RCS platform to offer a better user experience, more efficiency and cost-effectiveness when compared to other solutions.

Telecommunications and Insurtech Markets

The global telecommunications market was valued at $1.74 trillion in 2019 and is expected to grow at a CAGR of 5% from 2020 to 2027. The steady increase is expected to be driven by the adoption of 5G and the increased popularity of Internet of Things (IoT) applications.

The Chinese telecom market was valued at $254.1 billion in 2017 and is also constantly expanding. The current Chinese telecom market is dominated by three mobile operators – China Mobile, China Unicom and China Telecom, which together are responsible for around 1.6 billion active subscribers (

In addition, the insurtech (insurance technology) market was valued at $2.72 billion globally in 2020 and is expected to grow at a CAGR of 48.8% from 2021 to 2028. The large increase is attributed to the rising use of technology solutions for everyday activities like acquiring insurance coverage (

Through its proprietary platforms and technologies, FingerMotion is uniquely positioned to capitalize on the telecom and insurtech markets’ growth and opportunities.

Management Team

Martin J. Shen is the Chief Executive Officer of FingerMotion Inc. He has over 15 years of experience in senior management roles within entrepreneurial startups and large multinational corporations. He has acquired a wide range of corporate management, financial oversight and operation administration expertise through these roles. In his most recent role, he founded Imperial Distributors (formerly known as AP Martin Pharmaceutical Supplies Ltd.), establishing the company as the preferred choice for distributional support to regional pharmacies throughout Western Canada. Before founding Imperial, Mr. Shen served as the Chief Operating Officer and Chief Financial Officer at Wales and Son Industrial (formerly Weir Minerals), a firm specializing in global delivery and support for mining slurry equipment. He began his career at PricewaterhouseCoopers in Vancouver, with work tours in the tax department in Singapore and the tax audit and advisory group in Hong Kong. Mr. Shen is a U.S. Certified Public Accountant and holds a Bachelor of Science from the University of British Columbia.

Lee Yew Hon is the company’s Chief Financial Officer. From 2006 until November 2020, he was the Chief Financial Officer of Cubinet Interactive Group of Companies, and he also took on the Chief Operating Officer role in 2011. During his tenure, he was instrumental in leading Cubinet and building teams across the Southeast Asia region, setting up financial processes within a short time. Mr. Lee spearheaded the growth of Cubinet to other regions, including Europe, the Middle East and Russia. He received his diploma from Tunku Abdul Rahman College in 1996. He is a Chartered Accountant, a member of the Malaysia Institute of Accountants (MIA) and an Associate Member of the Chartered Institute of Management Accountants, UK (ACMA).

Li Li is the Senior Vice President of FingerMotion. She recently served as Advisor to Shenzhen WuYiKa Technology Co. Ltd., a comprehensive service platform dedicated to online service distribution and payment. The company has become a fast and efficient provider of new media marketing solutions for the mobile internet. She has held high-level management positions with multiple industry names, including Hangzhou JiuYue Information Technology Co. Ltd. and Hangzhou LingXuan Information Technology. Ms. Li started her career in 2004, founding Shanghai ChuangYeZZ Network Technology Co. Ltd. and serving as its Vice President. With the close cooperation of local operators, the company launched SMS, MMS, WAP, mobile JAVA games, Hunan Satellite TV e-magazine and other wireless internet services to meet the rapid development of wireless internet and application requirements. She received her degree from Nanjing Academy of Engineering.

FingerMotion Inc. (FNGR), closed Friday's trading session at $3.84, up 2.9491%, on 201,964 volume. The average volume for the last 3 months is 8,194 and the stock's 52-week low/high is $0.62/$9.795.

Recent News

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV)

The QualityStocks Daily Newsletter would like to spotlight BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV).

BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing andcommercializing innovative immunotherapeutic products primarily forthe treatment of infectious and autoimmune diseases, was featuredin a recent report published by Zacks Small-Cap Research. In thereport, Zacks valued BVXV at $57.00/ADS. The publication reads, “OnNovember 30, 2022, BiondVax Pharmaceuticals Ltd. (BVXV) announcedfinancial results for the third quarter of 2022 and provided abusiness update. The company recently announced positivepreclinical results for its inhaled COVID-19 therapy. Using theindustry-standard hamster model for COVID-19 therapeutics, resultsshowed that hamsters treated with BiondVax’s NanoAb therapy hadsignificantly (P<0.001) less weight loss than hamsters treatedwith placebo. In addition, eight other parameters, including heartrate and social behaviors, indicated that the group treated withthe inhaled NanoAb experienced a shorter and milder illness. Weanticipate additional data from this study in the first quarter of2023. Assuming continued success, we expect BiondVax to initiate aPhase 1/2a clinical trial of the anti-COVID NanoAb in the fourthquarter of 2023.”

To view the full report, visit

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses.

In collaboration with the prestigious Max Planck Institute for Multidisciplinary Sciences (MPG) and the University Medical Center Göttingen (UMG), both in Germany, BiondVax is developing a pipeline of innovative nanosized antibody (NanoAb) therapies addressing diseases underserved by current treatments and with large and growing markets, such as COVID-19, asthma and psoriasis.

NanoAbs, also known as VHH-antibodies or Nanobodies, are alpaca-derived nanosized antibodies that exhibit multiple significant competitive advantages over existing antibody therapies, including stability at high temperatures, superior binding affinity, more effective and convenient routes of administration and efficient production. BiondVax is uniquely positioned to advance nanosized antibody innovation from R&D through commercialization.

The company’s highly experienced and successful pharmaceutical industry leadership team includes former senior executives from Novartis, GSK and Bristol-Myers Squibb.

Since its founding, BiondVax has executed eight clinical trials, including a seven-country, 12,400-participant Phase 3 trial of a prior influenza vaccine candidate, and it built, owns and operates a 20,000 sq. ft. state-of-the-art GMP biologics manufacturing facility housing its laboratories, production facilities and offices.

Lead Candidate: Inhaled COVID-19 NanoAb

In December 2021, BiondVax signed definitive agreements with the Max Planck Society – parent organization of the Max Planck Institute for Multidisciplinary Sciences– and the UMG to enter a strategic collaboration for the development and commercialization of innovative COVID-19 NanoAbs.

The company is planning a rapid development path that leverages its expertise and capabilities in biological drug development and manufacturing. BiondVax anticipates preclinical proof-of-concept results for an inhaled COVID-19 NanoAb by the end of 2022, with initial Phase 1/2a human clinical trial results expected in 2023.

The intended inhaled mechanism of delivery of BiondVax’s COVID-19 NanoAb formulation may serve as a significant differentiator when compared to approved monoclonal antibodies, which are injected. Inhaled delivery has shown to be cheaper, more convenient and likely safer for patients and providers.

NanoAb Pipeline: Psoriasis, Asthma and More

The COVID-19 NanoAb development agreement is part of a broader five-year research collaboration agreement signed in March 2022 covering discovery, development and commercialization of NanoAbs for several other disease indications with large market medical needs, including asthma, psoriasis, macular degeneration and psoriatic arthritis.

BiondVax has an exclusive worldwide license for development and commercialization of COVID-19 NanoAbs and exclusive options for similar worldwide licenses for NanoAbs for the above mentioned additional large market disorders currently underserved by approved therapeutic antibodies.

Academic research teams from MPG and UMG have verified strong affinity by the new NanoAbs to their biological target molecules and high thermostability. They have also demonstrated strong neutralization by several NanoAb candidates of their respective target molecules. Neutralization studies of the other NanoAbs are expected to begin later in 2022.

Based on the promising results, BiondVax will focus development efforts beginning with the following NanoAbs:

  • NanoAbs targeting IL-17 as drug candidates for the potential treatment of psoriasis and psoriatic arthritis
  • NanoAbs targeting IL-13 and NanoAbs targeting TSLP as drug candidates for the potential treatment of asthma

These are conditions for which the antibody target is validated by existing treatments and the mechanism of action is well understood. Both represent large medical needs and growing markets. BiondVax anticipates preclinical proof-of-concept for at least one of these NanoAbs in 2023. This is in addition to the aforementioned human clinical Phase 1/2a for the inhaled COVID-19 NanoAb therapy, which is also anticipated in 2023.

Market Opportunity

COVID-19 treatment, target of the company’s lead NanoAb therapy candidate, had an estimated market size of $22 billion in 2021.

Future BiondVax drug candidates will target conditions with large markets growing at attractive CAGRs.

The global asthma treatment market was valued at $18.08 billion in 2019 and is projected to reach $26.01 billion by 2027, exhibiting a CAGR of 4.5% during the forecast period, according to Fortune Business Insights. The research firm predicts that the global psoriasis treatment market will grow from $26.37 billion in 2022 to $47.24 billion by 2029, exhibiting a CAGR of 8.7% over the forecast period.

Management Team

Amir Reichman is BiondVax’s CEO. He previously was Head of Global Vaccines Engineering Core Technologies at GSK Vaccines in Belgium. Prior to that, he held leadership roles at Novartis Vaccines’ Global Vaccines Supply Chain Management organization. He was the first employee of NeuroDerm Ltd., a company focused on transdermal drug delivery, and served as Chief Engineer and Senior Scientist until his departure in 2009. He earned a M.Sc. in Biotechnology Engineering from Ben-Gurion University and an MBA in Finance and Health Care Management from the University of Pennsylvania’s Wharton School.

Tamar Ben-Yedidia, Ph.D., is Chief Science Officer at BiondVax. She has more than 30 years of experience in immunology, with specific expertise in the development of vaccines. She began her career with Biotechnology General Ltd., working on development of a recombinant Hepatitis-B vaccine. She later joined the Weizmann Institute of Science, working on the design of a peptide-based vaccine against several pathogens. She is widely published, with numerous refereed articles and invited reviews in various scientific journals. She received her Ph.D. from the Weizmann Institute.

Elad Mark is COO at BiondVax. He has over 15 years of biotechnology industry experience encompassing diverse project stages including feasibility studies, conceptual and detailed design, commissioning, qualification and process validation. Prior to joining BiondVax, he led Novartis’s $800 million investment in a biologics facility in Singapore. With Biopharmax and Antero, both global pharmaceutical engineering companies, he successfully led projects in Israel, China and Singapore. He holds a BSc. in Engineering from the Afeka Tel Aviv Academic College of Engineering and an MBA from the Open University of Israel.

Uri Ben-Or is CFO at BiondVax. He has served as CFO with public life science companies traded on the TASE, OTC and Nasdaq. Ben-Or provides his services to BiondVax through CFO Direct, a company he founded and for which he serves as CEO. He served as the VP of Finance of Glycominds, a leading biotechnology company, and as CFO of a spin-off from Telrad Networks. He also served as a Corporate Controller at Menorah Capital Markets and as an Auditor at PWC. He holds a B.A. in Business from the College of Administration, an MBA from Bar-Ilan University, and is a CPA.

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), closed Friday's trading session at $10.955, up 7.5063%, on 8,598 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $9.795/$.

Recent News

India Globalization Capital Inc. (NYSE American: IGC)

The QualityStocks Daily Newsletter would like to spotlight India Globalization Capital Inc. (NYSE American: IGC).

Cancer treatments often involve surgery, radiation and chemotherapy, which may beadministered separately or conjointly, in accordance with apatient’s treatment plan. Commonly prescribed potent chemotherapydrugs include cisplatin, which was first discovered in 1965 at Michigan State University. Cisplatin has proven to be an effective chemotherapy medication that can beuseful in the treatment of various solid cancers, including lung,ovarian, testicular, head and neck, bladder and stomach. However,this drug also causes many side effects, including nausea and vomiting; kidney toxicity, which may causekidney failure in roughly 35% of patients ingesting the drug; andperipheral neuropathy, which causes severe pain in an individual’sfeet and hands. Monitoring kidney function is especially crucialfor patients on cisplatin, as this reduces the risk of experiencingcisplatin-induced toxicity. So to help manage these symptoms,researchers have been conducting trials on already available medications in an effort to find some that can mitigate these side effects.Now, a recently conducted study has found that a drug known asistradefylline, which has been approved for use in treating Parkinson’s disease by the FDA, may help alleviate cisplatin’s negativeeffects. Pain is also another side effect that comes withconventional cancer treatment, and so far, not many solutions areavailable. Alternative treatments for pain, such as those beingdeveloped by India Globalization Capital Inc. (NYSE American: IGC), could offer hope to cancer patients facing chronic pain due totheir cancer treatment.

India Globalization Capital Inc. (NYSE American: IGC), through subsidiary IGC Pharma, develops, patents, and markets advanced THC-based drug formulations for the treatment of symptoms related to various diseases including but not limited to Alzheimer’s disease, Tourette syndrome, chronic pain, and pet seizures.

IGC’s leading drug candidate, IGC-AD1, has completed Phase 1 of a safety and tolerability trial and entered Phase 2 trials for treating agitation in patients with Alzheimer’s dementia, the first study in humans of a natural tetrahydrocannabinol (THC) compound plus another molecule ( As of September 2022, the IGC trial is the only ongoing Phase 2 trial of a natural THC-based formulation on Alzheimer’s patients.

The company’s other drug candidate, TGR-63, is an enzyme inhibitor that has shown in preclinical trials the potential to reduce neurotoxicity in Alzheimer’s cell lines. Both drug candidates have shown their ability to ameliorate beta amyloid plaques in Alzheimer’s cell lines and improve memory in Alzheimer’s mouse models. Beta amyloid plaques are a key hallmark of Alzheimer’s and an important target of Alzheimer’s pharmaceutical drug development.

Neuro Psychiatric Symptoms (NPS) are not only debilitating for Alzheimer’s patients; they also place an immense emotional burden on their caregivers. Beyond reducing symptoms, IGC-AD1’s active molecules and TGR-63 have also shown promise in preclinical trials to reduce important hallmarks of Alzheimer’s including plaques and tangles, as well as improving the treatment of memory loss.

Over the past eight years, the IGC team has amassed a deep knowledge of cannabinoid science, including extraction, isolation, purification, and development. The company’s strategy is to leverage its unique end-to-end capabilities, platform, and expertise to develop a class-leading program and bring it to market quickly and cost efficiently to treat neurodegenerative diseases such as Alzheimer’s.

The company also has a family of cannabidiol (CBD)-based consumer products ( such as pain relief creams, pain relief gels, purpose gummies, tinctures, and capsules targeting women’s wellness, with a particular focus on premenstrual syndrome (PMS) and dysmenorrhea (period cramps). In addition, the company targets individuals that need sleep-aids with its specially formulated low melatonin cannabinoid gummies.

IGC has also introduced a low-calorie CBD- and caffeine-infused energy beverage brand ( that is currently available for purchase. The company’s brands are founded on the belief that effective natural solutions should be affordable and accessible to everyone. As the demand for natural products targeting women’s wellness and energy drinks continue to grow, these products are seeing strong traction in the market.

The company operates three facilities – a large GMP (Good Manufacturing Production Standards) certified facility that includes extraction, distillation, and manufacturing, in Washington State; a GMP-211 (pharmaceutical) grade facility in Maryland; and a facility licensed for controlled substances including cannabis in Bogota, Colombia, with complete access to legal licensed cannabis where the company conducts its testing.

In addition, the company’s development under Magistral Formulations is approved by INVIMA (Colombia National Food and Drug Surveillance Institute) to treat neurological disorders, non-oncological chronic pain, and mental disorders.

IGC’s intellectual property (IP) portfolio comprises of eight patents that it controls and seven patent applications. The portfolio includes #11,446,276, a patent for extreme low dose THC treatment of Alzheimer’s that was granted in September 2022.

The company is headquartered in Potomac, Maryland.


IGC-AD1 is the company’s leading drug candidate for the treatment and relief of Alzheimer’s symptoms. A significant amount of research on Alzheimer’s cell lines has shown that the active agents in IGC-AD1 reduce plaques and neurofibrillary tangles that are the hallmarks of Alzheimer’s. Further, micro-dosing of THC, as shown in cell lines, could increase the functioning of mitochondria and potentially promote the growth of new neural pathways (neurogenesis). The research shows that micro-dosing of THC affects the brain radically differently from the normal higher dosing of THC.

While there is a significant body of research showing that THC is neuro-toxic at normal levels of dosing, micro-dosing of THC has been shown to be non-toxic to neurons. With the results of these preclinical studies, the company developed an oral formulation, IGC-AD1. The company recently completed a safety and tolerability Phase 1 trial on Alzheimer’s patients and has initiated a Phase 2, multi-site, double-blind, randomized, placebo-controlled trial of the safety and efficacy of IGC-AD1 on agitation in participants with dementia due to Alzheimer’s disease at sites in the U.S. and Canada. IGC expects the Phase 2 trial to take between 9 and 12 months to complete, barring unknown factors such as, for example, a resurgence of COVID and the enforcement of lockdowns and travel restrictions.

With further successful trials and FDA approvals, IGC hopes to bring a drug based on natural THC as an effective treatment for agitation in Alzheimer’s to market.


The company’s other molecule, TGR-63, has been shown to reduce the neurotoxicity that impacts memory loss in preclinical trials with mice. On a dose dependent manner, transgenic Alzheimer’s mice treated with TGR-63 showed improvement in memory relative to control.

Both drug candidates, IGC-AD1 and TGR-63, have shown their ability to reduce the brain plaques associated with memory loss in Alzheimer’s in mice.

With further successful trials and FDA approvals, IGC hopes to bring TGR-63 as a treatment for Alzheimer’s disease to market.

Market Opportunity

Alzheimer’s disease impacts over 55 million people worldwide and about 5.5 million individuals in the U.S. Over 70% of these patients face debilitating symptoms, including anxiety, depression, and agitation (Mendez, 2021). Agitation in dementia patients can include excessive physical movement and verbal activity, restlessness, pacing, belligerence, aggression, screaming, crying, and wandering.

In 2020, the estimated healthcare costs for Alzheimer’s disease in the U.S. were $305 billion. Medicare and Medicaid covered about 70% of those costs, leaving considerable burden on patients and families. At the current rate of growth of Alzheimer’s and other dementia diagnoses, those costs are estimated to reach over $1 trillion by 2050.

Currently, there are no FDA-approved medications to alleviate the symptoms of dementia due to Alzheimer’s disease, providing a tremendous opportunity for formulations that can have an impact on quality of life and disease progression.

Management Team

Richard Prins has been chairman at IGC since 2012 and served as an independent director since 2007. From March 1996 to 2008, he was the Director of Investment Banking at Ferris, Baker Watts, Incorporated. Prins served in a consulting role to RBC until January 2009. He currently volunteers full time with a non-profit organization, Advancing Native Missions, and is a private investor. Since February 2003, he has been on the board of Amphastar Pharmaceuticals Inc. He holds a bachelor’s degree from Colgate University and an MBA from Oral Roberts University.

Ram Mukunda is CEO and President of IGC. He has been the chief inventor and architect of most of the company’s patent filings and is responsible for the company’s strategic positioning. Prior to IGC, he was founder and CEO of Startec Global Communications, which he took public in 1997. He served as Strategic Planning Advisor at Intelsat, a communications satellite services provider. From 2001 to 2003, he was a Council Member at Harvard’s Kennedy School of Government, Belfer Center of Science and International Affairs. He was named the 1998 Ernst & Young Entrepreneur of the Year. He holds bachelor’s degrees in electrical engineering and mathematics, and a master’s degree in engineering from the University of Maryland.

Dr. Jagadeesh Rao is the company’s Principal Scientist. His career spans two decades in the public sector and product R&D for Johnson & Johnson. He leads IGC’s scientists in the development of pharmaceutical and OTC products. He worked for the federal National Institutes of Health, and for the National Institute on Drug Abuse. His Ph.D. in Neurochemistry is from the National Institute of Mental Health & Neurosciences in India. He did postdoctoral training at the University of Illinois-Chicago.

Claudia Grimaldi is a Director, Vice President, Principal Financial Officer, and Chief Compliance Officer for IGC. She also serves as a Director/Manager Director for some of the company’s subsidiaries. She graduated with highest honors from Javeriana University in Colombia with a bachelor’s degree in psychology. She holds an MBA, graduating with highest honors, from Meredith College in North Carolina. In addition, she has attended the Darden School of Business Financial Management Executives program and the Corporate Governance Program at Columbia Business School. She is currently pursuing her Directorship Certification with the National Association of Corporate Directors. She is fluent in both English and Spanish.

India Globalization Capital Inc. (NYSE American: IGC), closed Friday's trading session at $0.4036, up 2.1514%, on 75,774 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.37/$1.29.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has hired RonalDixon as its general manager of government sales; Dixon will focuson U.S. government vehicle procurement programs. With more thanfour decades of experience, Dixon has an impressive resume,including serving for more than 20 years as a leader on GeneralMotors’ Federal Government Fleet Sales Team, responsible for allaspects of bidding, contract approvals and price negotiations; overthe course of his career, Dixon was responsible for selling morethan 500,000 units to the U.S. federal government. The strategichire aligns with Mullen’s 100% EV product portfolio and the federalgovernment’s plans to increase their fleets with electric vehicles,the company said, noting that the Biden administration issued anexecutive order last year mandating that the government replace itsentire fleet of some 650,000 vehicles with American-made EVsAccording to the announcement, Dixon will concentrate his effortson establishing Mullen’s EV lineup, including its Commercial Class1-3 EVs and Bollinger Motors, within the overall federal fleetprocurement process. “This was a strategic move on our part tobring Ron in and open the door to government fleet salesopportunities,” said Mullen Automotive CEO and chair David Micheryin the press release. “His experience is a perfect match for us andour vision for commercial EV sales success.”

To view the full press release, visit

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Friday's trading session at $0.198, up 3.8825%, on 102,774,611 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.18/$7.15.

Recent News

Cub Crafters Inc.

The QualityStocks Daily Newsletter would like to spotlight Cub Crafters Inc.

CubCrafters, the leading designer and manufacturer of light-sport,experimental and Part 23 certified backcountry aircraft, wasfeatured in recent articles published by FLYING Magazine and General Aviation News. The publications discuss selection of CubCrafters flagshipcertified CC19 XCub by the United States Department of Agriculture(“USDA”) Wildlife Services for a new government aircraft fleetmodernization contract. “The XCub will be used in place of theUSDA’s fleet of 30-plus-year-old legacy Piper PA-18 Super Cubs thatare currently in service. The USDA utilizes turbine-poweredhelicopters and single-engine airplanes in multiple operations,such as the aerial application of herbicides, fertilizer andinsecticides, surveying crops and wildlife, feeding fish, theapplication of seed in remote areas, and for support of wildlandfire-fighting services. Airplanes are usually significantly lessexpensive to operate than helicopters, said Brad Damm, CubCrafters’vice president of sales and marketing, noting the operational costof one of their Cubs is about $250 per hour while a turbine-poweredhelicopter runs approximately $2,500 per hour,” the FLYING articlereads. The piece further quotes Damm discussing deliverables underthe contract. “The first two aircraft [for the USDA] are inproduction now and scheduled for delivery in August and Septemberof 2023,” Damm said. “Under the contract, they have fixed priceoptions to purchase additional aircraft in both 2024 and 2025. Ourgoal here at CubCrafters is to provide them with such a goodplatform (an aircraft that is more capable, more cost effective,and safer), that they ultimately replace their entire current fleetof around 40 legacy aircraft with the XCub.”

To view the full articles, visit and

Cub Crafters Inc. (typically styled CubCrafters) is an OEM aircraft manufacturer based at McAllister Field Airport in Yakima, Washington. The company was founded in 1980 to build parts and supplementary type certificate (STC) improvement modifications, which were used to establish it as the preeminent center for rebuilding the classic Piper PA-18 Super Cub light aircraft. CubCrafters went on to advance the market with its own, newly manufactured aircraft models and holds an approved Federal Aviation Administration (FAA) Production Certificate. Yakima-based operations include an engineering design-test-certification center, aircraft parts and assembly production facilities, and an MRO maintenance service and overhaul facility.

The first newly manufactured aircraft by the company, the CC18-180 Top Cub, was Federal Aviation Administration (FAA) type certified in December 2004. The Top Cub was also granted type certificates (TC) by Transport Canada in July 2008, followed by Australian certification in August of that same year. With the FAA’s release of the new Light Sport Aircraft (LSA) class, CubCrafters created a brand-new model in 2008, the CC11-100 Sport Cub, similarly based on the original Piper J-3 Cub’s appearance, which it validated to ASTM international standards as an LSA. This model advanced to become known as the Carbon Cub, the bestselling LSA of all time in the U.S.

CubCrafters focuses on four main product lines, including the Carbon Cub SS, Carbon Cub FX, XCub, and the Top Cub under license. Some models are built to be lightweight and powerful for quicker flights, while others are built for longer missions in unforgiving backcountry environments.

CubCrafters has a service and overhaul facility for PA-18 Super Cubs and other Cub derivative designs at its Yakima headquarters. The company sells aircraft kits as well as finished aircraft.


The Carbon Cub is available in three variants: Carbon Cub SS (production Light Sport Aircraft), Carbon Cub FX (an innovative Builder Assist E/A-B aircraft) and Carbon Cub EX (E/A-B aircraft kit). Carbon Cub has been designed for off-airport operation with a powerful engine, strong lightweight airframe and nimble low-speed manners. The Carbon Cub has taken the fundamentally superior design of the Piper Super Cub and reinvented it using 21st century materials and computer-aided design. Superior engineering results include the Carbon Cub having 50% fewer parts and weighing more than 300 pounds less than a similarly equipped Super Cub. Now in its third generation of innovation advancements, there are over 1,000 Carbon Cubs flying.

The CubCrafters CC19-180 XCub, FAA Certified and introduced in June 2016, is supplied complete and ready-to-fly. The XCub is a further scaled development of the CubCrafters Carbon Cub, which the company continues to supply, but with higher performance and incorporating more structural carbon fiber. The XCub was developed over a six-year period and not publicly announced until FAA TC had been completed and issued. The process was completed organically using company resources and did not involve any venture capital, loans nor any advanced customer deposits. XCub is built on a wholly original fuselage design. The CNC-milled 4130 chromoly steel frame meets the latest FAA Part 23 certification standards for 2,300-pound gross weight aircraft. XCub’s useful load is as high as 1,084 pounds. Current Part 23 certification requirements ensure this is the strongest Cub ever produced. It can fly farther, providing greater comfort. It is an airplane that has taken the best from the past and, using the very latest in design, material and manufacturing technology, has established a new standard.

The XCub was approved by the FAA for seaplane operations in December 2017. That same month, EASA approved the XCub design and issued a new type certificate. Four international type certificates have been gained: EASA Dec-2017, Canada Feb-2018, Japan April-2018, and Australia Aug-2018.

CubCrafters increased the horsepower of the XCub line in 2019, offering two new models: the CC19-215 FAA Certified version and the CCX-2300 Builder Assist, both powered by the new CC393i 215 HP engine built by Lycoming.

In December 2021, CubCrafters gained FAA Certification of a new nose wheel version of the XCub, branded the NXCub.

Market Overview

According to a 2022 analysis by research firm Expert Market Research (“EMR”), the global ultralight and light aircraft market was valued at $7.63 billion in 2021. The EMR report says the market is expected to grow at a CAGR of 4.5% in the forecast period of 2022-2027 to reach a value of $9.93 billion. Ultralight and light aircraft are small aircraft with on-board pilot (and perhaps passengers) designed for use in recreation, sports, pilot training, aerial surveys, mapping, research and agriculture, humanitarian backcountry access, and special military missions, as well as business and personal travel.

CubCrafters currently enjoys a dominant market share of the rugged adventure airplane market.

Management Team

Patrick Horgan is President and CEO at CubCrafters. Before he assumed that role, he was the company’s Vice President/Director of Engineering & Product Development for three years, when he led the FAA Part 23 type certificate approval and production certificate approval of CubCrafters’ newest flagship, the XCub. Mr. Horgan also directed the breakthrough certification that authorized the use of experimental avionics in FAA-certified production aircraft, a first in aviation history. He brings over 30 years’ aircraft development and manufacturing experience in general aviation, commercial, and military industries. Prior to service at the company, he was the General Manager at WACO Classic Aircraft Corporation in Battle Creek, Michigan, and was the commercial aircraft manager of the Boeing 777 wheel and brake program for Goodrich Aerospace in Troy, Ohio. He was also a designer on the F/A-18 Super Hornet at McDonnell Douglas (now Boeing) in St. Louis, Missouri. Mr. Horgan holds degrees in aeronautical and astronautical engineering from the University of Illinois, and a certificate in Disruptive Strategy from Harvard Business School. He serves as a member of the Board of Directors of the General Aviation Manufacturers Association and on ASTM aircraft standards committees.

Brad Damm is Vice President at CubCrafters. He has overseen CubCrafters’ sales, marketing, and brand management operations since 2018. Since first joining CubCrafters in 2013, Mr. Damm has served as Factory Direct Sales Manager, the Director of Sales Support, the Global Director of Sales, and the Vice President of Sales and Marketing. During his tenure, the company has seen new sales records year after year across all of CubCrafters new aircraft and kit product lines, and the CubCrafters brand has risen to new levels of awareness and respect with aviation consumers worldwide. Prior to joining the company, he served for over 10 years as the Business Development Manager for one of the largest commercial concrete contractors in the Pacific Northwest, driving the sales and revenue growth that allowed the company to expand from a few dozen to hundreds of employees.

Rick Johnson is the Director of Finance at CubCrafters and has been with the company since 2017. He has 27 years of previous experience as controller and CFO for fruit packing and timber operations in the Pacific Northwest. He holds a Bachelor of Science in Business Administration from Central Washington University.

Christopher Matus is Production Manager at CubCrafters and joined the company in 2011. Before taking that post, he held positions as Fabrication Plant Manager, Machine Shop Manager and CNC Machinist for the company. He has also served as a Combat Engineer in the Washington Army National Guard, deploying to Afghanistan and to natural disasters including the 2014 Oso Mudslide.

Justin Jansky is the Administrative Manager at CubCrafters. He joined the company in 2015 and has a demonstrated history of successful collaboration on major FAA type certification projects in the general aviation industry, specifically under 14 CFR Parts 21 and 23. He is responsible for process management, document control, facilitating FAA certification processes, coordination with FAA delegates and documenting compliance testing. He holds a bachelor’s degree in technology and applied design.

Recent News


REZYFi, Inc.

The QualityStocks Daily Newsletter would like to spotlight REZYFi, Inc.

Marijuana industry regulators in the state of New Jersey haveapproved regulations for “public marijuana consumption areas,” taking the state a step closer to permitting social consumptionfor patients and adults. Shops selling marijuana opened their doorsthis April, but advocates are insisting on the necessity ofestablishing regulations that would accord users more spaces forlawful cannabis consumption. Recently, New Jersey’s CannabisRegulatory Commission (CCR) moved close to achieving this whenthey approved requirements to oversee the consumption venues as well as fees that businesses which operate those sites have topay. Currently Cannabis is accessible to everyone 21 years of ageor older who wishes to partake of the substance responsibly, in asafe and legal area. When the above is regulated well, cannabisconsumption kiosks could boost the industry and also give consumersa variety of choices on consumption sites, said CRC chair DiannaHouenou. As enterprises such as REZYFi Inc. step up their support to the cannabis industry, the country islikely to see more businesses opening in the space despite the lackof access to funding from mainstream banks.

REZYFi, Inc. is a cannabis mortgage bank servicing the needs of both traditional and non-traditional consumers and businesses. Its target markets include licensed and permitted cannabis companies, owners of real estate who lease to cannabis companies, and companies and individual homeowners seeking a variety of real estate-related first and additional mortgage-based financing and project-specific financings, such as solar installations and real estate development projects.

Headquartered in Miami, Florida, REZYFi operates through two wholly owned subsidiaries – REZYFi Lending, which primarily addresses emerging real estate-related financing opportunities, and ResMac Inc., the company’s traditional mortgage origination, correspondent and servicing operation. REZYFi is currently licensed in 34 U.S. states, with plans to expand to all remaining states later this year.

REZYFi is positioned as one of first cannabis mortgage bankers in the U.S., while most traditional lenders are still reticent to serve the state-licensed cannabis industry.


REZYFi Lending

REZYFi Lending leverages a wide network to offer options such as 15- and 30-year fixed-rate loans, FHA loans, VA loans, reverse mortgages, jumbo loans and adjustable-rate mortgages.

Looking ahead, the company expects increased funding in marketing and loan agents to drive significant origination growth over the next two years, further supported by the planned launch of a high-margin cannabis division later this year.

ResMac Inc.

ResMac has been in operation for 13 years, having closed more than 20,000 loans for more than 15,000 clients. The company expects to accumulate $285 million in retail origination in 2023, alongside $250 million in wholesale origination for the same period. ResMac is further targeting $600 million in origination through its mortgage correspondent operations for 2023.

Through its ResMac subsidiary, REZYFi operates as a direct lender and originator of residential mortgages, with active mortgage correspondent and mortgage servicing operations. Through its correspondent segment, ResMac primarily purchases and aggregates residential mortgages from trusted third-party originators.

The company intends to harvest the database of customers within its mortgage servicing operations as an essential source of additional growth, especially relative to the new alternative residential loan programs being offered.

Corporate Strengths

  • Experience – REZYFi is led by a seasoned management team with significant expertise spanning a wide range of real estate and financing subsectors. The team also has extensive experience in the cannabis and hemp marketplace, which the company intends to leverage as it navigates the changing landscape of the cannabis industry while sourcing the best opportunities in the sector.
  • Network of Independent Brokers – Over the past five years, REZYFi has developed an extensive network of independent mortgage-related brokers and licensed loan officers. The company is currently training the network members on its new service offerings, with many already launching sales efforts. REZYFi believes this network will be a vital asset moving forward as other firms in the sector terminate relationships in the face of slowing mortgage business in a rising interest rate environment.
  • Proprietary Technology – REZYFi has invested heavily in designing, building and implementing proprietary automated/machine learning technology to shorten loan processing timeframes and increase efficiencies, allowing it to operate its legacy business at staffing levels meaningfully below those of its competitors.

Market Overview

REZYFi’s diversified approach to the real estate lending sector positions it to capitalize on growth in multiple verticals in the years to come.

In the first quarter of 2022, lenders issued 2.71 million residential loans, with the average balance for a first mortgage climbing to a record high of $298,324 in 2021, according to the Mortgage Bankers Association. This trend is expected to continue, with Freddie Mac forecasting a 10.4 percent increase in home prices in 2022 and a 5.0 percent bump in 2023. Growth prospects in the cannabis industry paint a similar picture.

The National Association of Realtors® issued a report in April 2021 examining the correlation between cannabis legalization and real estate demand. In states where prescription and recreational cannabis use is legal, more than a third of surveyed agents reported an increase in demand for warehouses. Likewise, 23 percent of those surveyed reported an increase in demand for storefronts, and 28 percent observed increased demand for land. As other states look to join the 19 that have embraced full cannabis legalization, this rising demand could create an opportunity for REZYFi’s cannabis-focused initiatives.

In total, an analysis by market research firm Business Research Insights projects the global loan servicing market to reach a value of nearly $1.5 billion by 2028, up from $680.8 million in 2021. Those figures represent a CAGR of 11.0 percent during the forecast period of 2022-2028.

Management Team

John Vu, Esq., is CEO of REZYFi, Inc. He has more than two decades of experience in the mortgage and commercial banking industry. He has filled many senior and executive management positions in high-producing mortgage banks, including C-level assignments. He has also served as general counsel for a nationally associated commercial bank. Mr. Vu brings considerable cannabis industry expertise to REZYFi. He has served as a corporate attorney to multiple cannabis cultivators, manufacturers and retailers.

Ji Ji Zhang, Esq., is CFO of REZYFi, Inc. He is a multifaceted entrepreneur who owns a law firm, a portfolio of hotels and a high-producing mortgage bank. Mr. Zhang is also an investor in the development of a cannabis business park. He brings more than five years of experience in mortgage banking to REZYFi, having developed Freddie Mac and HUD licenses and amassed a managed portfolio valued at over $300 million.

Kevin Heckemeyer is President of REZYFi, Inc. He has more than 25 years of experience in mortgage banking. He has built and sold several high producing mortgage businesses. In his current roles with ResMac, he is responsible for production and operations.

Spencer Dang is Chief Credit Officer of REZYFi, Inc. He has more than a decade of experience in mortgage operations. He is a direct endorsement underwriter for HUD and has specialized in non-QM underwriting. Under his watch as an underwriter, he has never had a single repurchase.

Recent News


GeoSolar Technologies Inc.

The QualityStocks Daily Newsletter would like to spotlight GeoSolar Technologies Inc.

• Homes in the US are increasingly resorting to electricity tosatisfy their power requirements, shifting away from their priormixed-fuel use model

• All electric homes can resulbt in carbon emissions which are 81%lower than their mixed-fuel counterparts whilst simultaneously,resulting in significant utility-related cost savings

• GeoSolar Technologies have sought to cater to the ongoingelectrification of US households through their proprietarySmartGreen(TM) Home system

• A recent housing development in Riverside County, California haslooked to test the dual concepts of green energy powered householdsand a microgrid – insulating homes within the community fromfailures in the state power grid

If you were to acquire a home constructed at any point over thepast forty years, chances are that it is an all-electric home. Asurvey carried out by the US Energy Information Administrationfound that 35% of hom es built in 1980 or later used onlyelectricity, with 25% of all homes nationwide now solely employingelectricity to satisfy their power requirements ( A recently published research study has now revealed that notonly do all-electric homes result in substantial carbon emissionssavings over their mixed-fuel powered counterparts – over 81% loweron average, but they also boast a far more inexpensive costprofile. Wirrrthin New York alone, an all-electric home was shownto result in net present cost savings of as much as $6,800 relativeto a mixed-fuel home over the course of the 15-year study.

The carbon emissions savings of an all-electric home have beenwarmly welcomed by local state governments; cities in California,Washington, New York, and Massachusetts have all passed laws oradopted codes mandating or encouraging all-electric new buildingconstruction. Meanwhile, regional coalitions across the country areforming to extend lessons learned from these first movers to otherstates, including in New England and the Midwest. The desire bygovernmental bodies and homeowners alike to lower carbon emissionsand decrease utility costs has sparked a drive towards householdelectrification and consequently, a transition away from theyesteryear model of mixed-fuel use households. It is exactly thiskind of vision that GeoSolar Technologies (“GST”), a Colorado-based climate technology company has looked tocater to.

GeoSolar Technologies Inc. (“GST”) is a Colorado-based climate technology company and the creator of the Smart Green Home® system for newly built and existing residences and commercial buildings. The company is focused on revolutionizing the way we heat, cool and power homes with 100% natural energy sources. Its patent-pending integrated system harnesses energy from the earth and sun to power and purify homes and automobiles without the use of fossil fuels.

In a GST home, the sun’s energy is captured on the roof to generate all of the electricity required. Additionally, the consistent climate of the earth is used to keep the home at a perfect temperature year-round, and the company’s proprietary air purifying unit ensures that the air inside the home is safe and healthy.

GST’s home technology has been installed in multiple test homes in Colorado and achieved exceptional results, including some of the most impressive energy efficiency ratings (HERS) in the industry.

GeoSolar Technologies is currently accepting investment as part of a Regulation A+ offering. Everyone* can invest now for as little as $300. For more information, visit the company’s profile on Manhattan Street Capital and review its Offering Circular.

GeoSolar Technologies Inc. (“GST”) has been qualified by the U.S. Securities and Exchange Commission (SEC) to conduct a Regulation A+ capital raise. GST is already a publicly traded company who makes quarterly and annual filings with the SEC and is subject to quarterly PCAOB audits. This is the first time shares of GeoSolar Technologies are being made available for public purchase. Upon completion of this Regulation A+ offering, the company intends to seek a listing of its stock.


The Decarbonization Movement

Soaring and unstable energy/fuel costs continue to highlight the importance of rethinking the traditional approach to powering homes, from top to bottom. While most everyone is well aware of the remarkable, multi-trillion-dollar opportunity the electric vehicle transformation offers to investors (in addition to the benefits to the climate problem), few recognize that the all-electric home market is as large as electric vehicles and equally important to reducing carbon emissions.

U.S. energy expenditures clocked in at $3,891 per person in 2018, leading to estimated spending of $1.3 trillion on energy that year alone. Despite this, fewer than 3% of U.S. homes are currently powered by solar. This number is poised to increase exponentially as both new and existing residences transition to zero carbon models.

GST estimates that if all the homes in America were powered by its technology, carbon pollution could be reduced by an estimated 1.9 trillion pounds per year, greatly reducing the negative impacts on our climate.


The GeoSolarPlus (“GSP”) system combines solar power, geothermal ground-sourced energy and other clean energy technologies into one fully integrated system.
Key benefits of the GSP system include:

  • Making a real planet-changing difference in reducing air pollution
  • Eliminating or significantly reducing homeowners’ future utility bills
  • Enjoying lifetime energy independence and protection from price escalation and energy shortages
  • Eliminating greenhouse gas emissions from operation of home and daily life
  • Increasing home value
  • An integrated design for seamless operation of renewable energy systems
  • Maintaining a significantly healthier living environment
  • Leveraging existing renewable energy tax credits and electrification incentives
  • Creating stable jobs capable of supporting families in the decarbonized future

Click here to learn more about how GeoSolarPlus works.

Management Team

The GST leadership and management team includes some of the world’s most experienced and respected leaders in the fields of decarbonization and sustainable homes.

Stone Douglass is the Chairman and CEO of GST. He is a seasoned, 30-year public company executive and former Chairman and CEO of the Piper Aircraft Company.

Brent Mosbarger is the company’s Co-Founder and leads its commercial operations. He is a highly respected solar engineer whose experience includes roles with Chevron Energy’s green operations and serving as project manager and executive for a $400 million solar/geothermal innovation project.

Peter Romenesko is a Senior Strategic Advisor with GST. He brings to the company considerable experience as an engineer and large-scale project manager for Johnson Controls and Siemens.

Dr. Norbert Klebl is the company’s Co-Founder and Development Director. Recognized as one of the world’s leading experts in the field of zero-carbon innovation, he is a former McKinsey partner of 16 years with an MBA from Columbia.

Dar-Lon Chang is GST’s Director of New Product Development. Prior to joining GST, he had a 16-year career with ExxonMobil Energy Research. He received his PhD in engineering from the University of Illinois.

* Must be over 18, certain states are not currently available and will be added soon.

Recent News


Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services (OTCQB: SHRG) is dedicated to maximizing shareholder value through theacquisition and development of innovative companies, products andtechnologies. SHRG has an ownership interest in The Happy Co.,which offers functional beverages, capsules, patches and creamsthat elevate mood, boost energy, reduce stress, enhance sleep,increase muscles, minimize fat and tighten skin, helping users feeland perform like a younger person, and MojiLife, a leader in thedirect-selling fragrance sector. “In the last three years, TheHappy Co. has become the category creator for Happy Coffee, therecognized leader in natural nootropics, and is one of thefastest-growing companies in the social-marketing anddirect-selling industries,” a recent article reads. “In addition,Kristine Widtfeldt took over the reins at MojiLife, a company thatoffers the AirMoji device, a fragrance dispenser featuring thelatest in innovative technology and design. According to theannouncement, the AirMoji’s modern, compact, wireless designdoesn’t require open flames, heated light bulbs or melted wax, andthe device is ideal for scenting homes, vehicles and other spaces.”

To view the full article, visit

Sharing Services Global Corporation (SHRG), formerly Sharing Services Inc., is a diversified company dedicated to maximizing shareholder value, operating through two primary subsidiaries: Elepreneurs Holdings, a direct-selling company, and Elevacity Holdings, a products company. Headquartered in Plano, Texas, SHRG markets and distributes Elevate-branded health and wellness products through an independent sales force of distributors called Elepreneurs.

Proprietary Products

SHRG’s current exclusive Elevate product offerings are marketed under the Elevacity brand, so named to signify the company’s commitment to elevating lives.

The Elevate health and wellness product line consists of nutraceutical products that SHRG refers to as D.O.S.E., which stands for dopamine, oxytocin, serotonin and endorphins – all of which are key hormones proven to promote happiness and well-being.

Elevacity brand products are carefully formulated, chosen and designed to support a single objective: elevate the happiness and well-being of the consumer.

Global Network of Elepreneurs

Elevacity products are shared and sold by a growing international network of home-based entrepreneurs, called Elepreneurs, operated by Elepreneurs Holdings. This SHRG subsidiary provides basic and advanced programs for both new and experienced entrepreneurs who are focusing on their direct-sales careers.

SHRG’s high-performing independent sales force follows the company’s Blue Ocean selling strategy, an approach that encourages individuals to seek new markets, lead, and to “stop competing and start creating.” The Blue Ocean strategy is based on the book, “Blue Ocean Strategy,” written by Professor Renée Mauborgne, who notes that “the lesson here is that the best defense is offense, and the best offense… is to make a blue ocean shift and create your own blue ocean.”

Following this selling strategy, SHRG’s Elepreneurs are taught that, rather than competing directly in a competitive, direct-selling market, they should focus on making competitors irrelevant and succeeding in an uncontested marketplace.

In addition, SHRG’s Elepreneurs use the interactive, video-based VERB sales-marketing platform developed by Verb Technology Company Inc. The app utilizes proprietary interactive video data collection and analysis technology and provides next-generation customer relationship management, lead generation, and video marketing software applications.

Continued Momentum as Industry Leader

These selling strategies have resulted in sharp and consistent revenue gains. In the company’s 10-Q filed with the SEC for the three months ended Oct. 31, 2019, SHRG reported sales of $38.8 million for fiscal Q2 2019, an increase of 116% over sales of $17.9 million reported for the comparable quarter of 2018. Consolidated gross profit jumped by $16.2 million to $27.4 million for the same period compared to Q2 2018.

SHRG’s consolidated operating earnings were $3.9 million in the fiscal quarter ended Oct. 31, 2019, compared to $866,802 for the comparable period the prior year. Consolidated gross margin also grew 70.9% for the three months ended Oct. 31, 2019, compared to 62.2% the prior year.

These numbers are continuing a trend established over the past two years. In fiscal Q1 2019, SHRG achieved revenues of $35.4 million, more than double that of the comparable period in 2018. Even earlier, the company reported sales of $85.9 million for fiscal year ended April 30, 2019. This represents a nine-fold increase, or $77.5 million jump, over the company’s revenues of $8.4 million the prior year.

These numbers bring SHRG’s sales revenues since December 2017 — when the company’s Elevate product line was released — to an impressive cumulative total of $169 million.

Preparing for Success

SHRG is well prepared to continue and accommodate for this growth. The company recently expanded its corporate footprint by moving to a 10,000-square-foot facility in Plano, Texas, that offers ample room to expand as the company grows and flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

In addition, the company has a seasoned, expert leadership team in place, led by John “JT” Thatch. Thatch was appointed president and CEO of SHRG in March 2018, bringing to the company his expertise obtained from successfully starting, owning and operating several businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist SHRG as the company aims to expand and increase revenues.

469.304.9400 x 201

Sharing Services Global Corporation (SHRG), closed the day's trading session at $1.01, up 23.17%, on 276,351 volume with 217 trades. The average volume for the last 3 months is 279,074 and the stock's 52-week low/high is $0.27/$2.54.

Recent News

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF)

The QualityStocks Daily Newsletter would like to spotlight Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF).

On Sun, Dec 11 at 5:30pm ET broadcast on FOX Business News - BTV-Business Television visits up-and-coming innovative investment opportunities.Eloro Resources Ltd. (OTCQX: ELRRF) (TSXV: ELO) - The global energy transition createssoaring demand for silver and tin. With five active drills on theirflagship project in Bolivia, Eloro is on the verge of a majordiscovery.

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) is a publicly traded exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec.

The company has an option to acquire a 99% interest in the highly prospective Iska Iska Property, classified as a silver-tin polymetallic epithermal-porphyry complex, a significant mineral deposit type in the Potosi Department of southern Bolivia. Iska Iska is a road-accessible, royalty-free property.

Eloro also owns an 82% interest in the La Victoria Gold/Silver Project, located in the North-Central Mineral Belt of Peru, some 50 kilometers south of Barrick’s Lagunas Norte Gold Mine and Pan American Silver’s La Arena Gold Mine. La Victoria consists of eight mining concessions and eight mining claims encompassing approximately 89 square kilometers. La Victoria has good infrastructure, with access to road, water and electricity, and is located at an altitude that ranges from 3,150 meters to 4,400 meters above sea level.

The company has a strong management and technical team working diligently to uncover the value of both Iska Iska and La Victoria. Eloro is based in Toronto, Canada.


Iska Iska – Potosi, Bolivia

Iska Iska is associated with a Miocene possibly collapsed/resurgent caldera, emplaced on Ordovician age rocks with major breccia pipes, dacitic domes and hydrothermal breccias. The property is wholly controlled by the title holder, Empresa Minera Villegas S.R.L. It is located 48 kilometers north of Tupiza city, in the Sud Chichas Province of the Department of Potosi. This is an important mineral deposit type in the prolific South Mineral Belt of Bolivia. Eloro commissioned a NI 43-101 Technical Report on Iska Iska, which was completed by Micon International Limited and is available on Eloro’s website and under its filings on SEDAR.

A fully financed drill program is currently underway on the property, situated near world-class deposits including Silver Sand, San Bartolomé, Pulacayo, San Cristobal, San Vicente, Chorolque, Tasna, Choroma and Siete Suyos. Iska Iska is in the southwest part of the Eastern Cordillera, which hosts a number of major polymetallic mines and mineral deposits. Drilling and continuous channel sampling results have demonstrated some very high metal values, especially silver and tin, within an immense system, where mineralization has been encountered in every drill hole to date. The company believes there is excellent potential for world-class bulk mineable deposits.

La Victoria – Ancash, Peru

The La Victoria project, targeting gold and silver production, is situated near world-class, low-cost gold producers Pan American Silver and Barrick Gold Corporation. Located in Ancash Department, La Victoria sits on the western slopes of the Peruvian Andes. The property is located 12 hours from Lima, with a travel distance of 600 kilometers. The nearest road accessible population centers from La Victoria are Huandoval, Pallasca and Cabana. The project includes four principal mineralized zones in Peru’s prolific North-Central Mineral Belt – San Markito, Victoria, Victoria South and Ccori Orcco – with excellent potential for gold discovery. Operations at La Victoria are planned to proceed with a 2,000-meter diamond drilling program to test targets to outline potential resources at San Markito. Trenching and sampling confirmed high silver values and veins at San Markito in 2020.

Market Outlook

According to industry association The Silver Institute, the outlook for silver demand is exceptionally promising, with global demand forecast to rise to a record high of 1.112 billion ounces in 2022. The increase will be driven by record silver industrial fabrication, which is forecast to improve by 5%, as silver’s use expands primarily in solar energy and electric vehicle (EV) manufacturing. The institute states that government commitments to carbon neutrality have resulted in a rapid expansion of green energy projects, driving record photovoltaic panel installations which are expected to lift silver demand in this segment to an all-time high in 2022.

Rising demand in the electronics industry is also boosting the demand for tin, which is primarily used in solder. The electronics and electrical industries use solders containing 40-70% tin, which provide strong and reliable joints under a variety of environmental conditions. At present, the majority of the assemblers are using patented tin-and-copper-based solders. Mordor Intelligence estimated tin demand at 387 kilotons in 2021 and forecasts demand growth of 2.5% annually through 2027. Over the medium term, surging demand from the EV market and increasing applications in the electrical and electronics industry is expected to drive the market.

Management Team

Thomas G. Larsen is CEO of Eloro. He has more than 40 years of experience in the investment industry, specializing in corporate finance and management of junior resource companies, raising in excess of C$200 million. He previously held the position of President and Chief Executive Officer of Champion Iron Limited. Prior to that, he was President and Chief Executive Officer of Champion Iron Mines Limited.

Dr. Bill Pearson is Executive VP of Exploration for Eloro. He has more than 40 years of direct experience in the exploration and production of minerals worldwide. He played an integral role in the acquisitions of Desert Sun Mining Corp. by Yamana Gold in 2006 and Central Sun Mining by B2 Gold in 2009. He was formerly VP Exploration at Desert Sun Mining and Senior VP at Central Sun Mining.

Miles Nagamatsu, CPA, is CFO at Eloro. He has over 30 years of experience in accounting, management, lending, restructurings and turnarounds. Since 1993, he has acted as a CFO of public and private companies primarily in the mineral exploration and investment management sectors. He holds a Bachelor of Commerce degree from McMaster University.

Osvaldo Arce Burgoa is General Manager at Eloro. He is a geological and mineral processing engineer with 26 years of experience in Bolivia. He is a former President of the Bolivian Geological Society, Main Technical Advisor of the National Mining Corporation (COMIBOL) and has served as exploration manager and chief geologist at various mining and exploration companies. He has authored two books on Bolivian geology and holds a doctorate in mining engineering from Tohoku University in Sendai, Japan.

Eloro Resources Ltd. (OTCQX: ELRRF), closed Friday's trading session at $2.78, off by 1.7668%, on 17,013 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $2.09/$4.46.

Recent News

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF)

The QualityStocks Daily Newsletter would like to spotlight EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF).

EverGen (TSX.V: EVGN) (OTCQX: EVGIF), a leading Canadian renewable energy company and Canada’srenewable natural gas (“RNG”) infrastructure platform, is confidentthat it is heading to a catalyst-rich quarter. “We’re one of thefirst movers in Canada in terms of consolidating assets across thecountry… We’ve taken an approach that we want to be a developerdeveloping new projects from scratch, an owner and an operator ofthese facilities, and to have a platform to be able to be inmultiple provinces to share resources. That’s been our strategy andwe’ve been effectively growing at a rapid pace with acquisitionsthat we’ve done in BC. This year we’ve done additional acquisitionsin Alberta. We’ve got a significant development project, projectRadius, the facilities in Ontario that give us our next leg ofgrowth. We are looking at other provinces for other developmentprojects that sit within our pipeline,” a recent article quotesEverGen CEO Chase Edgelow as saying. “It’s about having technicalexpertise in the RNG space, so having the personnel thatunderstands how to optimize these facilities, how to ensure you’redesigning a facility that will be resilient. Our team has seen overa hundred projects in the space and that really helps us have anadvantage with some of the smaller asset owners to be able to bringthese projects into our portfolio to share the upside with them andto be able to continue to develop and grow across the country.”

To view the full article, visit

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) is developing Canada’s Renewable Natural Gas Infrastructure Platform, starting on the west coast in British Columbia. The company is combating climate change and helping communities contribute to a sustainable future by acquiring, developing, building, owning and operating a portfolio of renewable natural gas (RNG), waste-to-energy, and related infrastructure projects.

While EverGen is currently focused on British Columbia, its continued growth is expected across other regions of North America. RNG is produced differently than conventional natural gas, without drilling wells. RNG is derived from biogas, which is captured from decomposing organic waste in landfills, food waste, agricultural waste matter and wastewater from treatment facilities. This waste feedstock is supplied to an anaerobic digester which contains bacteria that breaks down organic matter in the absence of oxygen. The resulting biogas is captured and cleaned to create carbon neutral or carbon negative RNG to be used by the existing North American gas pipeline grid. By capturing these emissions and transforming them into RNG, then combusting into CO2, the overall greenhouse gases (GHG) impact is materially less potent than allowing natural decomposition to release methane into the atmosphere. Liquid and solid digestate matter is a byproduct of the RNG production process and is used as fertilizer and in other applications.

EverGen operates three projects in British Columbia. The company was incorporated in 2020 and went public in 2021, with its common shares listed on the TSX Venture Exchange under ticker symbol ‘EVGN’. In February 2022, EverGen’s common shares began trading on the OTCQB Venture Market in the U.S. under ticker symbol ‘EVGIF’. The company is headquartered in Vancouver.

Portfolio Projects

Fraser Valley Biogas is one of three projects in EverGen’s portfolio. Located in Abbotsford, British Columbia, the facility has been digesting manure and off-farm organics since 2011 and was the first agricultural digester in Canada to produce RNG. The RNG generated through this project is part of a FortisBC program to supply renewable gas to homes, businesses and other customers. Fraser Valley Biogas also provides Abbotsford farms with renewable fertilizer via the digestate produced. EverGen acquired Fraser Valley Biogas early in 2021 and is currently enhancing and expanding the facility. These optimization projects resulted in record production during the month of September 2021, supporting the growing demand for RNG in British Columbia. Optimization activities contributed an additional 18% of RNG production for September and a 9% higher year-to-date production compared to the previous year. The facility produces approximately 80,000 gigajoules of RNG, enough to heat more than 1,000 homes for a year.

Net Zero Waste Abbotsford, a wholly owned EverGen subsidiary and portfolio project, is an existing composting and organic processing facility and RNG expansion project. The British Columbia Utilities Commission recently approved a 20-year offtake agreement between the facility and FortisBC, an electricity and gas utility. Under this agreement, FortisBC will purchase up to 173,000 gigajoules of RNG annually for injection into its natural gas system upon completion of an anaerobic digester project at Net Zero Waste Abbotsford. Once construction is complete, this project is expected to produce enough energy to meet the needs of more than 1,900 homes.

Sea to Sky Soils, a wholly owned EverGen subsidiary and portfolio project, is an existing composting and organic processing facility and potential future RNG expansion project which has been operating near Pemberton, British Columbia, on Lil’wat Nation land since 2012. The Lil’wat Nation is a key partner and supporter of the facility, which has employed a majority of its staff from the First Nation since inception. The Sea to Sky Soils facility processed approximately 160 percent of its forecast tonnage in the second half of 2021. In total, Sea to Sky Soils processed approximately 36,000 tons of organic waste in 2021. The facility is working with the Ministry of Environment to expand its operational capacity in 2022. EverGen has partnered with local municipalities – including Metro Vancouver and the municipality of Pemberton – for the delivery of additional organic waste to the facility. The facility is an important part of EverGen’s RNG infrastructure platform and serves as a source of valuable feedstock to support the company’s existing and future operations.

Market Outlook

A report from Global Market Insights states that the biogas market is projected to see significant growth over the next few years, driven by a shifting preference to utilize biogas to reduce emission levels from traditional fuels. Escalating RNG usage by gas utilities as a sustainable and low carbon alternative to supply heat and electricity in industries and buildings will further stimulate growth. RNG is increasingly deployed across the transport sector, especially for heavy vehicles and vessels, to abate GHG emissions.

Many North American gas utilities have set RNG targets of 5% to 15% of production by volume in 2030, compared to less than 1% by volume in 2020. FortisBC has a goal of including 15% RNG in its gas supply by 2030. EverGen believes this presents a potential C$16 billion+ opportunity for RNG producers.

Management Team

Chase Edgelow is co-founder and CEO at EverGen. He has over 15 years of specialized private investment, finance, and technical expertise in the energy and infrastructure sectors. His background is as a Facilities Engineer with Petro-Canada, independently managing energy infrastructure capital projects located in western Canada. He holds a Professional Engineer designation from the province of Alberta.

Mischa Zajtmann is co-founder and President at Evergen. He has 15 years of experience providing consulting and management for Canadian and American companies in the natural resources and energy space. He is a corporate securities lawyer who began his career at Blake, Cassels & Graydon LLP. His J.D. is from the University of Saskatchewan Law School. He’s a member of the British Columbia Bar.

Sean Mezei is COO at EverGen. He has 20 years of experience in the RNG industry, having served previously as the president of Greenlane Biogas and as a senior manager at QuestAir, and founder and president of Dekany Consulting. He was a co-chairman of the American Biogas Council’s RNG working group for six years. He has been a Registered Professional Engineer in the province of British Columbia since 1994.

Natasha Monk is CFO at EverGen. She is a CPA with 12 years accounting, financial reporting, and tax experience in public practice and industry. She is currently a partner at Affirm LLP, where she advises and consults to a wide variety of companies in multiple industries across public and private sectors. Prior to joining EverGen, she worked at KPMG. She graduated from the University of Calgary.

EverGen Infrastructure Corp. (OTCQX: EVGIF), closed Friday's trading session at $1.51, off by 0.657895%, on 5,300 volume. The average volume for the last 3 months is 5,300 and the stock's 52-week low/high is $1.365/$4.12.

Recent News

Flora Growth Corp. (NASDAQ: FLGC)

The QualityStocks Daily Newsletter would like to spotlight Flora Growth Corp. (NASDAQ: FLGC).

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor ofglobal cannabis products and brands, today announced its entry intosecurities agreements with institutional investors for the purchaseand sale of 12,500,000 of the company’s common shares, pursuant toa registered direct offering, and warrants to purchase up to12,500,000 common shares. According to the update, the combinedpurchase price for one common share and one warrant will be $0.40.Aggregate proceeds from the offering will be approximately $5.0million, from which the company expects to use net proceeds forcapital expenditures, to increase operating capacity, as well asfor working capital and other general corporate purposes. Subjectto the satisfaction of customary conditions, the offering isexpected to close on or about Dec. 13, 2022. A.G.P./Alliance GlobalPartners is acting as the sole placement agent for the offering. Toview the full press release, visit Kenneth Gay, a Michigan resident, has filed a lawsuit challenging the constitutionality the cannabis social equityprogram in Los Angeles. Gay has a stake in an LA-based company and had applied for a license under the social equity program. According to the suit, Gay hassubmitted his social equity application, but as of October 24,2022, the City of Los Angeles hadn’t completed verifying hiseligibility and yet a lottery to select licensees is slated forDec. 8, 2022. He filed his lawsuit on Nov. 30, 2022. Under LA law,to be eligible for the social equity program permit, one has tohave a prior arrest/conviction or come from a low-income area or anarea that has been negatively affected by police brutality. Gayclaims he qualifies in all the three categories, but the arresthappened in Michigan and not LA. In his suit, he argues that LA lawprovides preferential bias against out-of-state residents withregards to the social equity program lottery, yet the U.S.Constitution has a clause against such bias. On the other hand,many states’ laws allow marijuana, and it would be expected thatstates ought to be allowed to pass their own enabling laws withoutundue interference from federal agencies or laws. How this playsout is likely to be closely watched by companies that are active inthe marijuana industry in different jurisdictions, such as Flora Growth Corp. (NASDAQ: FLGC).

Flora Growth Corp. (NASDAQ: FLGC) is an internationally focused cannabis brand builder that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions, including cosmetics, hemp textiles, and food and beverage. Flora Growth operates one of the largest outdoor cultivation facilities in the world with an aim of marketing a higher-quality premium product at below-market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, the company creates premium products that help consumers restore and thrive.

Flora Growth completed the first traditional cannabis IPO on Nasdaq in May 2021. Although currently headquartered in Toronto, Ontario, with plans to relocate its head office to Miami, Florida, the company’s base of operations is in Colombia, where it has built an extensive distribution network that includes Colombia’s largest distributors.

Currently, Flora Growth is organically growing market share for its existing brand portfolio (pharmaceuticals, textiles, cosmetics, and food & beverage) while seeking revenue-generating acquisitions that offer an accretive distribution network to amplify revenue growth.

Existing Brand & Product Portfolio

Flora Growth’s portfolio spans a number of verticals – each with a thoughtful brand designed to resonate with its intended end consumer. In line with the company’s mission, each brand prioritizes natural ingredients and value-chain sustainability.

Flora Lab S.A.S

Flora Lab is the company’s GMP certified manufacturing and R&D center focused on producing pharmaceuticals, cosmetics, and nutraceuticals for domestic and international markets. Its offerings include product lines that are private label, white-label, and custom formulas.

Through Flora Lab, Flora Growth has relationships with 1,500+ distribution channels, manufactures 63+ OTC products registered with INVIMA (Colombia National Food and Drug Surveillance Institute), and holds multiple GMP certifications enabling international export in an effort to leverage Flora Lab’s capacity to produce a wide range of CBD-infused products.

Flora Beauty

Flora Beauty is the company’s CBD beauty and cosmetics division founded by fashion and beauty industry icon Paulina Vega. Its current offerings include two CBD skincare brands targeting the U.S. and Latin American markets – MIND NATURALS and AWE. These lines exemplify Flora Growth’s socially conscious approach to business.

Currently, Flora Beauty products are offered globally through e-commerce, as well as through Falabella’s 111 retail locations across Latin America. The company is in negotiations with major department stores to launch the line in the U.S. and is also exploring opportunities in the U.K. and other European markets.

KASA Wholefoods

KASA Wholefoods is a Colombian manufacturer of food and beverages leveraging responsibly sourced exotic fruits from the Amazon. KASA has a $10 million+ distribution agreement with Tropi, Colombia’s largest food distributor, which has 130,000+ distribution points across the country.

Mambe, KASA’s leading brand, is already offered through over 980 distribution points across Colombia. Flora Growth expects this network to grow to over 1,200 distribution points in 2021, including one of Colombia’s largest coffee chains, Tostao Café & Pan.

Hemp Textiles & Co.

Through its Hemp Textiles division, Flora Growth intends to utilize its large land package and cultivation infrastructure to capture market share in the rapidly growing hemp industrials segment.

The company’s first brand through this division, Stardog Loungewear, offers a line of comfortable loungewear made from natural, organic materials. Stardog has been distributing globally through e-commerce and brick and mortar channels in Bogota since fall 2020, and the company intends to open U.S. brick and mortar locations in 2021.

Accretive M&A

Flora Growth is targeting transactions to complete the supply chain via key infrastructure to enhance its global distribution with the aim to compete on low-cost, high-quality inputs paired with premium brands that create business lines with robust margins.

To date, Flora has announced two major transactions.

Koch & Gsell (Acquisition)

  • Amplify CPG portfolio’s revenue growth through leading brand, Heimat, currently with TTM revenues of $7.6 million.
  • Leverage Koch &Gsell’s distribution network of 2,500+ stores to introduce Flora to the Swiss, European and Asian markets.
  • Bring patented hemp cigarette manufacturing technology into new markets utilizing Flora’s high-quality cannabis.

Hoshi International (Investment)

  • Equity Investment of €2 million into Hoshi to establish Flora as a preferred supplier to two EU processing facilities.
  • Opens gateway for Flora Growth’s cannabis through international distribution agreements in the EU and U.K.
  • Hoshi’s experienced team and increased access to the EU cannabis market to serve as a catalyst for revenue growth.


Key to Flora Growth’s expansion efforts is its cultivation strategy. The company’s Cosechemos farm, located in Bucaramanga, Colombia, is currently licensed to cultivate 247 acres of cannabis. Through three successful pilot crop plantings, the location has demonstrated a production cost of just $0.06/gram. For comparison, the average cost of North American cannabis (based on 2019 figures from Aphria, Tilray, Sundial, and Aurora) equates to roughly $1.89/gram.
Flora Growth is uniquely positioned to capitalize on Colombia’s favorable growing conditions, low-cost infrastructure, and affordable local workforce as it looks to ramp up its cultivation efforts moving forward.

Leadership Team

Bernard Wilson is the Chairman of Flora Growth. A senior financial professional, Dr. Wilson is the former Vice-Chairman of PricewaterhouseCoopers LLP and is the Chairman of the Founders Board of the Institute of Corporate Directors. He has also served as Chairman of the Canadian Chamber of Commerce; Chairman of the International Chamber of Commerce – Canada; and Member of the Canada/U.S. Trade Committee. Dr. Wilson draws on this experience to ensure Flora Growth adheres to effective corporate governance practices.

Luis Merchan is the company’s President and CEO. He is a proven executive with over a decade of experience in enterprise sales management, corporate strategy, merchandising and expense management, and customer experience. Mr. Merchan previously served as Macy’s Inc.’s Vice President of Workforce Strategy and Operations, where he managed the enterprise’s multi-billion-dollar P&L expense line for the entire 540 store portfolio. Throughout his tenure at Macy’s, he led various sales and marketing initiatives, including the B2B corporate sales team that was responsible for $160 million in annual revenue. Mr. Merchan obtained his Bachelor of Industrial Engineering from Pontifical Xaverian University in Bogota, Colombia, and his MBA from McNeese State University. He also holds a Graduate Certificate in Marketing Management from Harvard.

Juan Manuel Galan is a Strategic Advisor to the Flora Growth management team. Mr. Galan currently serves as a senior consultant to The World Bank. He is a politician and former senator of Colombia, serving three terms from 2006 to 2018 as a member of the Colombian Liberal Party. He is also a former professor at the University of Rosario and holds more than 20 years of journalistic, academic, governmental and parliamentary experience. During his time as a senator, Mr. Galan was a key leader, with 29 bills and 27 debates on political control, and 17 laws to his name. The most relevant of those laws was authoring the medical cannabis law that resulted in the legalization of medical cannabis in Colombia.

Stan Bharti is a Director of Flora Growth. Mr. Bharti currently serves as Executive Chairman of Forbes & Manhattan. He has more than 30 years of professional experience in business, finance, markets, operations and more, with a focus on the resource and technology sectors. To date, Mr. Bharti has amassed over $3 billion worth of investment capital for the companies with which he has worked and their shareholders. He is a Professional Mining Engineer and holds a master’s degree in engineering from Moscow, Russia, and University of London, England.

Javier Franco is the company’s VP of Agriculture. Mr. Franco is a master horticulturist with more than 25 years of experience in the design, implementation, and management of cultivation and propagation facilities of more than 30 species of cut flowers in Latin America. He completed his agricultural studies at Zamorano University in Honduras and later at an International Exchange Program at Ohio State University. Mr. Franco has directed technical, commercial, and research groups in the cut flower, fruit and vegetable markets in Latin America and has participated in the commercial development of new technologies applied in agribusiness. He has also led the agri-management of organic crops and certifications of Good Agricultural Practices.

Flora Growth Corp. (FLGC), closed Friday's trading session at $0.3477, off by 21.8476%, on 2,211,224 volume. The average volume for the last 3 months is 2.211M and the stock's 52-week low/high is $0.3449/$2.38.

Recent News

MetAlert Inc. (OTC: MLRT)

The QualityStocks Daily Newsletter would like to spotlight MetAlert Inc. (OTC: MLRT).

MetAlert recently announced the signing of an LOI with Sensio Groupfor the marketing and distribution of RoomMate, a 3D Infraredsupervision product with a fall detection automated monitoringsystem

The company has set out to solve problems unique to individualsafflicted with ADA by creating devices specific to their use cases,and RoomMate is one such product, promising effective remotepatient monitoring while maintaining anonymity

Through this partnership, MetAlert looks to penetrate the high CAGRprojected patient monitoring devices market, valued at $47 billionin 2021

It also looks to leverage the partnership for future up-listingonto a major exchange such as NASDAQ

Its management is confident that with its value proposition andunique market positioning, it will soon position MetAlert as adominant player in its sector, commanding a significant marketshare and realizing substantial earnings

MetAlert (OTC: MLRT) is a pioneer in location-sensitive health monitoring devices andwearable technology products for remote patient monitoring. Thecompany was featured in a “Stocks to Watch” report published by Markets Herald, which offers current market trends and analysis across varioussectors. “MetAlert (OTC: MLRT) took a significant step forward inthe fourth quarter of 2022 by eliminating all toxic convertiblenotes from its balance sheet,” the publication reads. “This move,along with improved guidance to operations, provides investors withincreased stability to the public float. In addition, MetAlert islaunching new medical devices geared toward the geriatric andautism health care markets. With these developments, a recentreport price targets MetAlert now at $1 per share.” To view thefull report, visit

MetAlert Inc. (OTC: MLRT) is a pioneer in location sensitive health monitoring devices (estimated $47 billion industry in 2021) and wearable technology products (industry forecast to reach $174 billion by 2030).

With over 20 years of experience and an extensive patent portfolio (30+), MetAlert is a leader for consumers/patients afflicted with Alzheimer’s, dementia, and autism (ADA). This market represents approximately 2.9% of the world’s population (approximately 34 million people in 24 developed countries). Due to specific behaviors (problems with memory, adversity to wearing unknown items, etc.) of consumers/patients in this market segment, traditional products, such as an iPhone or Fitbit, are not a practical solution. This has created a significant market with very few competitors for MetAlert.

MetAlert and its subsidiaries are engaged in designing, developing, manufacturing, distributing, and selling products and services in GPS/BLE wearable technology, personal location, wandering assistive technology, and health data collection and monitoring. The company offers a global end-to-end hardware, software, and connectivity solution, in addition to developing two-way tracking technologies, which seamlessly integrate with consumer products and enterprise applications.

Using its award-winning, patented GPS SmartSole® as a hub for collecting and transmitting data to the cloud in real-time, MetAlert is expanding its value proposition to consumers and increasing its revenue per user (RPU) while creating the largest database of health statistics for ADA consumers/patients. MetAlert generates revenue from product sales, recurring subscriptions, intellectual property (IP) licensing, and professional services. The company has international distributors servicing customers in over 35 countries and is an approved U.S. military government contractor. Its customers include public health authorities and municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes and consumers.

The company is headquartered in Los Angeles, California, with a sales office in London, England, and distributors across the globe.


  • GPS SmartSoles® HUB (launched Q4 2022) is a GPS/BLE-equipped insole that allows remote monitoring, data collection, and encrypted data transmission to the cloud.
    • Telehealth (available Q4 2022) allows access remotely to doctors and other health professionals on an as-needed basis. This service will also function as the prescribing doctor once Medicare reimbursement codes are established.
    • Concierge (available Q4 2022) provides 24/7/365 enhanced emergency response that coordinates with all relevant parties to quickly detect false alarms and escalate response as needed.
    • Bluetooth Enabled Devices (available Q1 2023) include third-party devices that collect vitals and other health data and connect with the GPS Smartsoles® HUB.
    • Artificial Intelligence (available Q1 2023) software will evaluate the Teradata of health information identifying trends and respond to preestablished alert thresholds.
  • Take-Along Tracker is a small GPS tracking device – less than three inches long – that works with 4G cellular service and will have the same “HUB” functionality as the GPS Smartsoles®. This versatile and affordable mini tracker boasts super long battery life, with up to 14 days of operation per charge.
  • RoomMate™ is a wall-mounted alert system that detects and alerts caregivers about patient behavior that could lead to falls and injuries. The system features 3D infrared and wall-mounted sensors, eliminating the need for any other physical installation or wearables. RoomMate™ offers patient privacy by design. Images are not stored, but all actions are logged. It’s a unique solution for looking after patients without intruding on their personal space.

Market Outlook

According to Grand View Research (Patient Monitoring Devices Market Size & Share Report, 2030), the global patient monitoring devices market size was valued at $47.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.8% from 2022 to 2030. The expansion of the industry can be attributed to the rise in demand for monitoring devices used to measure, distribute, record, and display a variety of biometric data, including blood pressure, temperature, and blood oxygen saturation level.

The growing number of chronic disorders, such as diabetes, stroke, and kidney disease, are driving the demand for patient monitoring devices. For instance, according to the World Health Organization (WHO), about 422 million people globally have diabetes. Likewise, the number of asthma and chronic obstructive pulmonary disease patients (COPD) is increasing rapidly.

According to the WHO, around 235 million people suffer from asthma. As a result, peak flow meters, which are used to gauge respiration rate, are increasingly used. The market for patient monitoring devices is driven by the simplicity with which it is handled, transported, and remotely accessible. Major market players are engaging in a variety of tactics to expand the industry, including partnerships, cooperation, innovation, launches, and mergers.

During the COVID-19 outbreak, social segregation and quarantining procedures were put into place worldwide. Many people avoided regular hospital visits as a result. Many people now need routine home temperature and oxygen level monitoring to maintain track of their health, thereby demanding monitoring devices at home.

Various government programs are supporting the pandemic outbreak. The FDA has granted Emergency Use Authorizations (EUAs) for a few wearables and patient monitoring devices to improve access to medicines, monitor patients more closely, and lessen the risk of SARS-CoV-2 exposure to medical professionals during the COVID-19 pandemic.

The growing popularity of wearable and remote patient monitoring devices is another factor fueling the market’s expansion. By fusing clinical symptomology with vital indicators, wearable technology helps in the diagnosis of many chronic diseases. Thus, there has been a dramatic rise in the usage of wearable technology to combat COVID-19.

The wearable medical device market is anticipated to reach $174.48 Billion by 2030, expanding at a 27.1% CAGR during the forecast period (2022-2030), according to Market Research Future.

MetAlert identifies the total addressable market for its wearable patient monitoring tech for those with Alzheimer’s, dementia, and autism at more than 34 million potential patients in North America, Europe, South Africa, and Asia.

Management Team

Patrick E. Bertagna is Founder, CEO and Chairman at MetAlert. He began his career in apparel sales in 1983 and was promoted to national sales manager within two years. In 1986, he founded his first company importing apparel from Europe and selling to U.S. retailers from JCPenney to Neiman Marcus. He has founded several technology and apparel companies, including MetAlert in 2002, which he took public in 2008. He attended Cal State University Northridge with a business major and a psychology minor.

Louis Rosenbaum is COO of MetAlert. He co-founded Global Trek Xploration and was an initial investor in MetAlert. He has successfully started companies in multiple industries, including apparel, environmental services, and the music industry, achieving annual revenues in the multi-millions of dollars. He previously was president of Elements, a women’s apparel company, and of Advanced Environmental Services.

Alex McKean is CFO at MetAlert. He is also the CFO of Encore Brands Inc., a position he has held since 2009. He has held positions as Controller and VP of Finance at 24:7 Film and, Director of FP&A/SVP at Franchise Mortgage Acceptance Company, Corporate Accounting Manager/Treasurer of Polygram Filmed Entertainment and Assistant Treasurer/Controller for State Street Bank. He holds an International MBA from Thunderbird School of Global Management and undergraduate degrees in business and political science from Trinity University.

MetAlert Inc. (OTC: MLRT), closed Friday's trading session at $0.44, off by 2.2005%, on 3,450 volume. The average volume for the last 3 months is 3,450 and the stock's 52-week low/high is $0.06/$1.00.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.